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ABSTRACT

IDENTIFICATION AND CHARACTERIZATION OF LOW PH-TRIGGERED
CONFORMATIONAL CHANGES IN THE HERPES SIMPLEX VIRUS
GLYCOPROTEIN B

By Stephen J. Dollery, B.Sc. (Hons)

A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor
of Philosophy at Virginia Commonwealth University.

Major Director: Anthony Nicola Ph.D.
Associate Professor, Department of Microbiology and Immunology

Herpesviruses can enter host cells by pH-dependent endocytic pathways in a
cell-specific manner. The role of pH in herpesvirus endocytosis is unclear. Herpes
simplex virus (HSV) is a paradigm for virus membrane fusion via a complex of
glycoproteins. HSV glycoproteins B, D and the heterodimer H-L are necessary and
sufficient for membrane fusion. This work analyzes the structure and function of HSV
glycoproteins B, D, and H-L at neutral pH, and at the physiological low-pH encountered
during endocytic entry. It is demonstrated that mildly acidic low pH triggers specific
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conformational changes in HSV gB at a pH of 5.7 to 6.0. The antigenic structure of gB
functional region I that is critical for fusion is specifically altered by mildly acidic pH both
in vitro and during entry into host cells. Point mutations within gB functional region 1 that
block membrane fusion still allow conformational changes in region 1. This suggests
that specific hydrophobic residues are essential for fusion domain insertion into the host
cell membrane but not conformational change. The detected conformational changes
were reversible, similar to other class III fusion glycoproteins. Exposure to mildly acidic
pH directly triggered the fusion function of HSV glycoproteins and caused gB, but not
other glycoproteins, to become more hydrophobic. The oligomeric conformation of gB is
altered at a similar pH range.
In addition, several approaches were used to monitor gB throughout glycoprotein
synthesis and maturation. It is shown that gB may cotranslationally fold and oligomerize
as it is synthesized on the ribosome. As gB matures it then alters conformation and/or
binding partner to form antigenically distinct populations of gB within the cell and virion.
I conclude that intracellular low pH induces changes in gB conformation that, together
with additional triggers such as receptor-binding, are essential for virion-cell fusion
during herpesviral entry by endocytosis.
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I. Introduction to herpesviruses
Classification and structure
The Herpesviridae are a large family of viruses that are traditionally identified
based upon virion architecture (167). Once identified, a herpes virus is then
subcategorized into one of three subfamilies based upon its tissue tropism. Nucleotide
homology is now also a key method for virus identification and classification (145).
Virions of the herpesviridae consist of a core containing a linear double-stranded DNA
genome that ranges from 124-230 kb in length. The genome is surrounded by an
icosahedral capsid of 162 capsomers (154). A proteinaceous layer of tegument engulfs
the capsid and spans out to associate with envelope proteins (106). The outermost
structure of the virion is termed the viral envelope. The envelope is a host derived lipid
bilayer into which viral glycoproteins are imbedded. Glycoprotein spikes protrude from
the virion envelope and are the first feature of the virus to interact with the host (71).
All herpes viruses produce virions during the lytic replication cycle, destroying the host
cell. Herpes viruses also undergo a latent phase in hosts that do not succumb to initial
infection. During latency, genomes retain the capacity to reactivate and cause disease
at a later date. Latency ensures life-long infection of the host.
The Herpesviridae are divided into three subfamilies based upon tissue tropism
(110).
Alphaherpesvirinae have a rapid life cycle, efficiently destroy infected cells and are
able to become latent in sensory ganglia.
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Betaherpesvirinae have a long life cycle, infected cells frequently become enlarged
and latency is commonly maintained in secretory glands, lymphoreticular cells and
kidneys.
Gammaherpesvirinae are generally host specific and usually replicate in either B or T
cells. Latency is usually maintained in lymphoid tissue.

Distribution in nature
There are over 200 identified herpes viruses that are highly disseminated
throughout nature. Divergent sources range from marine mollusks to humans. There are
eight known human herpes viruses of medical significance (Table 1) and numerous
economically burdensome veterinary herpes viruses.
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Table 1: The human herpes viruses

Name

SubFamily

Primary
Target cell
type

Latency

Means of
Spread

Associated
manifestations
Oral and genital
lesions, ocular
and neuronal
infection.
Oral and genital
lesions, ocular
and neuronal
infection.
Chicken pox,
shingles,
encephalitis

Herpes simplex-1
(HSV-1)

Alpha

Mucoepithelia

Neuron

Close contact

Herpes simplex-2
(HSV-2)

Alpha

Mucoepithelia

Neuron

Close contact

Varicella Zoster
virus (VZV)

Alpha

Mucoepithelia

Neuron

Respiratory and
close contact

Blymphocytes

Close contact,
transfusions,
tissue
transplant, and
congenital

Infectious mononucleosis,
various
lymphoma

Saliva

Flu like
symptoms.
Systemic
infection in
neonates and
immunocompromised.

Respiratory and
close contact

Roseola,
encephalitis

?

Roseola,
encephalitis

Epstein-Barr
Virus (EBV)

Gamma

B-lymphocyte,
epithelia

Cytomegalovirus
(CMV)

Beta

Epithelia,
monocytes,
lymphocytes

Herpes
lymphotropic
virus (HHV-6)

Beta

T-lymphocytes
and others

Human herpes
virus-7 (HHV-7)

Beta

T-lymphocytes
and others

Kaposi's
sarcomaassociated
herpes virus
(KSHV)

Gamma

Endothelial
cells

Monocytes,
lymphocytes
and possibly
others
Tlymphocytes
and others
Tlymphocytes
and others

Unknown

Adapted from references (148, 186).
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Close contact
(sexual), saliva

Kaposi’s
sarcoma,
Multicentric
Castleman's
disease, primary
effusion
lymphoma

Medical significance of HSV
Herpes simplex viruses, HSV-1 and HSV-2, are common, contagious, incurable
alphaherpesviruses. Herpes simplex derives its name from the Greek “herpein” which
means to creep. By middle age, life long HSV-1 infection is commonly estimated to be
present in 80% of individuals while HSV-2 prevalence is estimated at 30% (31). The
most common sites of primary infection are mucous membranes irrespective of virus
type. Primary infection is usually the most serious. Recurrent reactivation from latency is
normally only painful (187). Herpes simplex is the leading cause of sporadic fatal
encephalitis, and also causes meningitis, myelitis, and radiculitis in other areas of the
nervous system.
Neonatal infection occurs in around 1 to 2000-5000 births and is frequently lethal.
HSV is the predominant cause of genital ulcerative disease (190). HSV is accepted as a
major contributing factor in the spread of HIV. Increased contact with blood at areas of
ulceration, and increased concentration of HIV containing CD4+ cells at the site of HSV
infection, are believed to play contributing roles. A review of 19 studies showed that
people with HSV-2 have a 3 fold increased risk of contracting HIV (61). The same study
estimates, that in certain populations, up to 60 percent of HIV infections can be
attributed to HSV. A large fraction of the 33 million people living with HIV will have
contracted HIV due to HSV infection.
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Antiviral Drugs
There are several effective antiviral drugs against HSV. Acyclovir was the first to
be identified, numerous analogues are now available that are increasingly potent.
Acyclovir is a guanosine analogue prodrug that once metabolized inhibits viral DNA
polymerase (31, 91). Derivatives of acyclovir work via a comparable mechanism.
acyclovir and derivatives function only to manage infection. Acyclovir-resistant HSV is a
frequent cause of morbidity in the immunocompromised. Alternative drugs with different
modes of action are desired. The availability of current antivirals has not diminished the
prevalence of herpes simplex viruses. This may be because HSV can be transmitted
from an asymptomatic host.

Vaccines
There are many candidate vaccines that fall under four main groups, some of
which have proved relatively successful in animal models. A vaccine for genital herpes
is still desirable. However, pharmaceutical companies interest in this area has waned,
apparently due to the success of antiviral drugs. The main groups of possible vaccine
are, wild-type, inactivated, subunit and genetically engineered (live). Wild-type vaccines
have proven unsuccessful and in inactivated vaccines long-term protection has not
been established. Subunit vaccines and genetically engineered vaccine areas remain
the most likely strategies at proving successful (145). A subunit vaccine had some
success in phase III clinical trials.
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Herpes simplex structure
DNA Core
HSV-1 and 2 have genomes 152kb and 155kb in length respectively (109). The
genome is densely wrapped into a liquid crystalline state. Spermidine and spermine
may neutralize the phosphates. Both HSV genomes are structurally similar and contain
unique long and unique short (UL and US) regions that invert to form four isoforms
during replication (109). Immediate early genes map to near the termini of UL/US
regions. Early and late genes including glycoprotein-encoding genes are dispersed
within the UL and US components (Figure 1).
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Figure 1. HSV-1 map indicating the positions of important
glycoproteins
HSV glycoproteins are arrayed across the entire genome. Positions of glycoproteins
used in this study are indicated. The scale is in map units. UL is the unique long region
of the genome, US the unique short.
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Capsid
Herpes simplex virus is 180 -225 nm in size with a capsid approximately 100 nm
in diameter. The capsid has T=16 symmetry with a T=4 lattice structure (154). The
capsid is predominantly made of viral proteins (VP) 5, 26, 23, and 19 (174, 195). VP5 is
the major capsid protein, with 5 protomers present in pentons and 6 in hexons. VP26
forms rings above hexomers while VP23 and VP19 link adjacent capsomers (Figure 2).

Tegument
HSV tegument proteins are multifunctional. Functions include capsid transport,
and adaptation of the cell to virus production prior to capsid reaching the nucleus.
Proteins such as the Virion Host Shutoff protein down regulate host protein synthesis
while proteins such as VP16 are transcriptional activators of HSV (15). Tegument
proteins also have suggested roles in capsid transport, docking at the nuclear pore and
DNA translocation. It is known that upon virus binding there are signaling events that
cause destabilization of VP16 (111). Tegument protein ICP0 has also been shown to
have a role in regulating the proteasome dependent entry of HSV (45).

Envelope
The outermost layer of the virion is a host-derived lipid bilayer termed the viral
envelope. There are around 11 virally encoded glycoproteins and numerous other nonglycosylated proteins that are embedded in the envelope (145). It is believed that
several host proteins may also be incorporated into the virion although the exact

9

proteins and their functions are controversial. Cryoelectron tomography revealed that
there are on average 659 glycoprotein spikes per HSV virion. The glycoproteins are
arranged in a non-random fashion, forming clusters that predominate on one side of the
envelope (71).
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Figure 2: Cryoelectron tomograph of a HSV virion
A) A surface rendering of a HSV tomogram. Shown in dark blue is the virus envelope, in
yellow glycoprotein spikes protrude from the surface and appear arranged in a nonrandom fashion.
B) A segmented rendering showing the capsid in light blue, tegument proteins in
orange, and again in dark blue the virus envelope with yellow glycoproteins. Pp is the
proximal pole; dp the distal pole. The scale bar is 100 nm.
(Image reproduced with permission from the publisher (71)
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Viral lifecycle
Viral entry
Virus entry is the first and possibly the most critical step in the viral replication
process (1). Viral glycoproteins are responsible for the first interactions with the host
cell. gB, gD and gH-gL are essential for infection (135, 176). Other proteins, such as gC
and UL45, are known to augment entry or regulate membrane fusion (49, 80, 177). The
role of around 15 other membrane proteins in the endocytic entry of HSV is as yet
unstudied (49, 106). The first step in HSV entry is non-essential but augments entry. gC
and gB reversibly bind to heparan sulphate proteoglycans (HSPGs) (79, 172). This
functions to concentrate virions to the cell surface. The second step is an irreversible
ligand-binding event. gD binds with a cognate receptor. gD receptors identified include
nectins 1 and 2, HVEM, and 3-0 sulfated heparin sulphate (28, 97, 117, 126, 158, 173).
It is currently believed that nectin-1 and HVEM are the most important receptors in viral
pathogenesis. Upon receptor binding, gD undergoes a conformational change from a
prefusion closed conformation to an open pro-fusion conformation, allowing further
interactions to occur. However, the subsequent sequence of events is unclear.
It is known that upon receptor binding, gD interacts with gB and gH-gL either
sequentially or in a complex (7, 8, 68). gB is also known to bind to cellular receptors
PILRα and non-muscle myosin IIA. (5, 6, 153). The sequence of gB receptor binding in
relation to gD receptor binding is as yet unevaluated. The role of non-muscle myosin IIA
in directing fusion is also unevaluated. Additional cues for fusion are likely, and possibly

13

direct the site of membrane fusion. Following fusion triggering events, either gH-gL or
gB or a heterologous complex execute fusion of host and viral membranes. This may be
initiated through a state of hemi-fusion in which the outer leaflets of the two membranes
become one, but the inner leaflets remain separate until further conformational changes
in the fusion machinery occur (169). Pore formation then follows. The pore then
expands prior to complete de-envelopment and capsid and tegument release into the
cytoplasm. There are at least two possible sites of capsid release into the cell
(discussed in the HSV entry pathway section).
After de-envelopment the capsid is transported through the cytoplasm to the
nucleus by anterograde microtubule transport (Figure 3) (155). Capsid transport is
proteasome dependent (45). DNA enters the nucleus through pores, and importin-β
helps translocate DNA into the nucleus (129).
The nucleus is the site of viral transcription, DNA replication, encapsidation and
the starting location of capsid egress (138). The nucleus is rearranged and
compartmentalized to facilitate these events. There is breakdown of the nucleolar
membrane. ICP0 causes the disruption of ND10 structures leading to conversion to prereplication compartments (107, 159). DNA first appears near ND10 sites, there then
forms replication compartments that coalesce and eventually fill the nucleus,
condensation of host cell chromatin is also observed as this is occurring, it is believed
that this also contributes to the host gene shutoff (118). Later on in infection the
chromatin disperses around the nucleus and the nuclear lamina is disrupted (23, 130).
Host proteins such as p53, DNA recombination and repair proteins, and IRF-3 are
recruited to replication sites, however their roles remain to be elucidated (43, 188).
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Viral gene expression
There are around 80 genes expressed in a highly regulated cascade (82, 145).
Host RNA polymerase II transcribes all the viral genes in the nucleus (4).
At 2-4 hr PI, in the absence of any other protein production “immediate early” (IE) gene
transcripts are produced. IE genes usually encode transcription factors such as VP16
that stimulate “Early” (E) gene expression. Between 4-8 hrs early gene products are
produced. This requires IE transcription factors but no DNA replication (83). Early gene
products are involved in the viral DNA metabolism (145).
Late gene expression peaks after viral DNA replication (39). Viral DNA is known
to circularize rapidly after infection and DNA replication is thought to occur via rolling
circle replication. Late genes are typically structural components of the virion including
viral glycoproteins.

Capsid assembly
Capsid assembly occurs in the nucleus. VP5, the major capsid protein, forms
hexon and penton capsomers. VP26 forms at the tips of hexons (122). The minor
capsid proteins, VP19C and VP23, hold capsomers together. These form heterooligomers in a 1:2 ratio. The capsid forms around a scaffold protein UL26.5. Proteolytic
degradation of the scaffold protein is an essential step in capsid maturation (47). A
portal is formed at one vertex of the capsid. This is comprised of 12 units of UL6 and is
believed to associate through interactions with VP26. Translocation of DNA into the
capsid occurs through the portal vertex. The encapsidation of DNA relies upon
numerous proteins but the core elements are UL28, UL15 and UL33, which form a
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terminase complex (16). The terminase cleaves concatemeric DNA into unit length
genomes and drives DNA through the portal.

Egress
Capsids are too large to egress through the nuclear pore and so egress though
the nuclear membrane via envelopment and de-envelopment (56). Following assembly,
capsids align along the inner-nuclear membrane and undergo a process known as
primary envelopment. UL31 and UL34 are thought to disrupt nuclear laminins helping
capsids bud into the perinuclear space (140). These capsids gain a primary envelope in
the process. For de-envelopment, gB and gH-gL act redundantly to fuse the primary
envelope with the outer nuclear membrane, releasing the capsid into the cytoplasm.
US3 kinase is believed to regulate fusion mediated by gB via phosphorylation of gB’s
cytoplasmic tail.
Transport of the capsid through the cytoplasm to the site of secondary envelopment is
mediated via microtubular transport. Attachment to microtubules may be via UL37p,
ICP0 and VP1/2 (46). In neuronal cells egress of membrane associated capsids may
be dependent upon the tegument protein UL36p (155). UL20p/gK and UL11p are
needed for the cytoplasmic envelopment of virions (64, 105) . Secondary envelopment
occurs as the capsid buds into a vesicle that contains markers of the trans-Golgi
network and endosomal membranes (76). Release of virus into the extra-cellular space
occurs as the vesicle fuses with the plasma membrane (175).
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Figure 3. HSV life cycle
1. Envelope glycoproteins interact with cell surface molecules; virions accumulate
and are endocytosed into a lysosome terminal endocytic pathway.
2. At the appropriate low pH the viral envelope fuses with the vesicular membrane
releasing capsid and tegument into the cytoplasm. Fusion is dependent on gB, gD,
gH-gL, gD receptor. Low pH is essential but the role is unclear.
3. There is proteasome dependent capsid transport to the nuclear membrane.
Capsid docks at a nuclear pore; genomic DNA is released and imported.
4. The HSV gene expression cascade ensues. This culminates in DNA replication
and packaging of unit length genomes into nascent capsids.
5. Egress begins. Capsids undergo gH- and gB-dependent envelopment/deenvelopment to escape the nucleus. Capsids are then transported along
microtubules to the site of secondary envelopment
6. Parallel to capsid egress (red arrows), viral membrane glycoproteins are
synthesized on the ribosomes of the endoplasmic reticulum. They are transported to
the Golgi apparatus where they undergo complex glycosylation.
7. Glycoproteins progress through the secretory pathway to a site of assembly
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8. Additional tegument proteins are added to capsids in the cytoplasm. Capsids are
then re-enveloped as they bud into vesicles containing markers of the trans Golgi
and endosomes. Virions at this point are now infectious but trapped in the cell.
9. Virions are then either released via exocytosis or released during cell lysis.
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Immune modulation
Herpes simplex viruses go unnoticed in their hosts for extended periods of time.
Herpes simplex carefully modulates the host immune response to evade clearance. It is
still unknown why HSV is periodically able to overcome the immune system and cause
outbreaks while at other times it is suppressed. The ability of the virus to become latent
is an excellent way for the virus to evade the immune system. There are no known
interactions with the immune system during latency.
During lytic infection HSV modulates the host’s response at many levels. HSV
ICP0 has been shown to be important in blocking the production of numerous
interferons (54, 104, 114). HSV has also been shown to reduce Jak1 and Stat2
activation in the infected cell. The reduction was again linked to ICP0 and also to the
VHS gene (32). Interaction with Toll receptors at both the cell surface, and in
endosomes is one of the first interactions of virus with its host cell. Activation of Toll
receptors can result in multiple cascades of antiviral activity. HSV is thought to
associate directly (bind) or activate indirectly (viral DNA) with TLR1, 2, 3, 7, and 9. TLR2
maybe particularly important in HSV encephalitis (100). HSV has the ability to
inactivate both classical and alternative components of the complement pathway. This
has the effect of protecting both cell free virus and virus in infected cells. HSV-1 gC
binds to the complement protein C3b and it is thought that this activity can block the
otherwise inevitable cascade (62, 84). HSV ICP47 is believed to down regulate surface
MHC-1 thereby blocking CD8+ T-cell activation (193). HSV ICP22 has been shown to
diminish CD4+ cell activation (14). HSV-infected dendritic cells do not undergo
maturation even in the presence of additional stimuli such as LPS and may enter an
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apoptotic state (89, 151). These effects have been attributed partially to the actions of
the VHS and ICP27 proteins (145). HSV has been shown to exhibit Fc receptor like
activity and can bind Ig. This activity has been attributed to glycoproteins G and I. This
has been shown to protect infected cells from antibody-mediated cytotoxicity (51). It was
also observed that an antibody complex forms when the Fab region of antibody binds
glycoprotein and Fc region of antibody binds Fc receptor. This complex was also
shown to make HSV resistant to neutralization by the classical pathway of complement
neutralization (60).

Multiple HSV entry pathways
The majority of animal virus families take advantage of endocytosis to
accomplish cell entry (131). For many years, it was thought that HSV entered cells
exclusively by fusing with the cell membrane with no requirement for endocytosis. More
recently it was demonstrated that HSV entry also proceeds via endocytosis. The entry
pathway utilized is now known to be cell type dependent. Active endocytosis is
necessary for HSV entry into several experimental cell types, but most importantly HSV
was shown to enter its primary site of infection, epithelial cells, via endocytosis (124,
125, 127). In contrast, entry into other neuronal cells and fibroblast cells, occurs by
direct penetration of the plasma membrane and has no apparent requirement for
endocytosis (36, 116, 124, 125, 127).
Both the endocytic and non-endocytic entry pathways share a number of
features. Study of the kinetics of initial uptake, trafficking, penetration, and virion capsid
delivery to the nucleus indicate, that entry by an endocytic mechanism is rapid, efficient
and leads to productive infection (127), as is the case for direct penetration at the cell
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surface. The completion of the entry process via either pathway requires participation of
gB and gD and the gH-gL (36, 127, 161)
Binding of virion gD to any one of its cognate receptors is a required component
of the HSV entry process (28, 40, 162). In the non-endocytic pathway, HSV engages gD
receptors at the cell surface and the capsid penetrates directly into the cytosol. In the
endocytic entry pathway, capsid penetration is spatially distinct from cell surface
binding. The enveloped virion is first taken up from the cell surface in a process termed
internalization. This step is essential for successful endocytic entry but does not occur in
the case of direct penetration at the plasma membrane. Internalization of HSV is rapid
but is not mediated by any of the known gD receptors (127). Endocytosed HSV
traverses a lysosome-terminal endosomal pathway that becomes lower in pH as the
virus approaches the lysosome. Endosomal low-pH is needed for endocytic entry but its
role is not clear. Trafficking of the virus to the site of intracellular penetration is also
independent of gD receptors. However, interaction with a gD receptor, either at the
plasma membrane or at an internal membrane, is required for release of the capsid into
the cytosol. In the absence of receptor interaction, virions are trapped within endocytic
compartments and ultimately undergo lysosomal degradation (127).
Common properties of viruses that utilize pH-dependent entry pathways include
(i) entry by an endocytic mechanism, (ii) requirement of endosomal low pH for entry; (iii)
inactivation of entry function by low-pH pretreatment of isolated particles, and (iv)
activation of membrane fusion function by acid pH (52). HSV fulfills the first three of
these four criteria, at least in certain cell types (124, 125, 127). HSV entry into cells that
support an endocytic entry pathway is susceptible to inhibition by lysosomotropic
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agents, which elevate the normally acidic pH of endosomes (125). However, HSV
penetration at the surface (of Vero cells, for example) is not inhibited by such treatment
(125, 191) and is considered pH independent. Consistent with a role for pH in
membrane fusion, treatment of purified HSV particles with a mildly acidic pH of 4.5 to
5.5 irreversibly inactivates entry activity (125).

The essential glycoproteins of herpes simplex entry
Envelope glycoprotein B
Envelope glycoprotein B is a single pass type I membrane glycoprotein. It is
approximately 904 amino acids long depending upon the strain of virus. gB is
expressed late in the lytic cycle of replication and is believed to function as a
homotrimer. gB is conserved among all herpesviruses. In all cases studied to date, it
plays multiple roles in viral entry, including receptor binding and membrane fusion. The
crystal structure of an ectodomain fragment of HSV type 1 (HSV-1) gB revealed an
elongated, rod-like structure containing hydrophobic internal fusion loops in domain I
(Figure 4) (78). This structure bears striking architectural homology to the low pH,
postfusion form of G glycoprotein from vesicular stomatitis virus (VSV-G) (Figure 5)
(142, 144). Both the gB and G structures have features of class I and class II fusion
proteins and are thus designated class III proteins (180). Antigenic analysis of gB has
mapped antibodies to several regions of gB (Table 2). Mutations that polarize
hydrophobic residues in putative fusion loops of gB result in defective membrane fusion
in a cell-cell fusion assay (74). Fusion loop mutants also result in reduced liposome
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binding (73). gB along with gH is needed for nuclear egress of the capsid through the
outer nuclear membrane. Mutations in the fusion loops of gB also diminish capsid
egress (192).
In synthesis and maturation, gB is known to oligomerize in the ER (35). It is
minimally glycosylated in the ER and is further glycosylated in the Golgi. gB binds to
chaperones calnexin, Grp78, and calreticulin in the ER (102). Disruption of the secretory
apparatus results in loss of incorporation of gB into virions (76, 88).

Envelope glycoprotein D
Herpes simplex gD is approximately 394 amino acids in length (Figure 6). It is
essential for membrane fusion and entry into the host cell. gD is found only in
alphaherpesviruses although other subfamilies of herpes viruses may have non
homologous proteins that function in a similar way. Structurally gD consists of a
receptor binding domain, an Ig like core, and a C-terminal pro-fusion domain (Figure 6).
gD is believed to form a homooligomer, possibly a homodimer. Functionally, gD is a
receptor binding protein that can utilize one of several cognate receptors (98, 117, 156,
160). Nectin-1 and HVEM are believed to be the most important in pathogenesis (161).
During receptor binding, gD undergoes a conformational change that moves the Cterminal region away from the receptor binding site(99). It is believed that this
conformational change converts gD into a profusion conformation. The C-terminal
region, sometimes referred to as the pro-fusion domain, may interact with gB/ gH-gL or
both (8, 10). Data for gD interactions with gB/gH-gL that lead up to fusion are not
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comprehensive. There are many antibodies to specific regions of gD. Those used in this
study are listed in Table 3.

Envelope glycoproteins H and L
gH-gL is a heterodimer that occurs at a one to one ratio. gH-gL is an essential
component of the fusion machinery and has homologues conserved throughout the
known human herpesviruses (25, 135, 176). gH is the largest component of the
complex. It is 838 amino acids in length (108, 133). gH is a type one single pass
glycoprotein with both N and O linked glycosylations. Sections of gH are reasonably
hydrophobic and were believed to be components of a fusion glycoprotein. The crystal
structures of several herpes virus gH-gLs have been resolved, revealing a structure
dissimilar to any known fusion glycoprotein (Figure gH-gL) (34). It is likely that HSV gHgL functions as a regulator of other fusion components(34).
gL is a 224 amino acid, non membrane anchored protein that associates with gH
during synthesis and folding in the endoplasmic reticulum. It is essential for the correct
folding and incorporation of gH into the virion and cell plasma membrane. gL is tightly
associated with gH in the crystal structure. The structure of HSV-2 gH-gL revealed a
“boot” shaped molecule (34). gH has three distinctly folded domains H1, H2 and H3 with
gL adding a single domain to heterooligomer. The domains have been termed the heel
(H1), the sole (H2) and the toe (H3) with gL forming the buckle (Figure 7).
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Other factors that influence entry
It is clear that other envelope proteins such as UL20, UL24, UL45, gM and gK
(11, 12, 49, 72, 112) are involved in the regulation of membrane fusion. However, the
study of fusion has been largely centered on the core glycoproteins essential for cell-cell
fusion. Dissecting the natural roles of all the envelope proteins is difficult due to the
number of possible regulatory interactions. There may be essential regulatory steps that
lead to fusion in vivo that are short cut by attempting to minimize the fusion machinery
to the minimum glycoproteins necessary for fusion.
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Figure 4. gB structure
A) Domain arrangement of HSV-KOS gB, Domains of gB are indicated by Roman
numerals and color coding. Disulphide bonds are indicated by blue bars joining paired
cysteines. TM is the transmembrane region. Linker regions between domains II and III
are indicated in purple.
B) A ribbon rendering of the crystal structure of gB. A monomer of the trimer is shown.
Color-coding and numeration are as in A. Regions disordered in the structure are shown
as dots.
C) A ribbon rendering of the gB trimer. One protomer of the trimer is colored as in A.
The remaining protomers are grey.
D) A surface rendering of C.
(Image reproduced with permission from the publisher (78)
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Figure 5. Structural homology of VSV-G and HSV-gB
Trimeric structures of prefusion (A) and postfusion (low pH) (B) proteins of herpes
simplex virus gB and VSV G. The protein backbone is shown in ribbon representation.
One protomer of each trimer is shown in color. Homologous protein domains are the
same color. The residue (aa 303) that is altered in an H126 MAb resistant (mar) mutant
is denoted in magenta spheres (CPK representation). Domain (D) designations in the
table are as originally assigned. Ribbon structures were prepared with PyMOL (44) after
(78, 142, 144).
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Table 2. Summary of monoclonal antibodies to gB used in this study

Antibody

Domain

a

Conformation

Neutralizing ?

d

b

-dependent ?

DL16

nd

Y (Oligomer

N

specific)
H126

I

N

Y

H1359

II-III

N

N

H1817

VI

N

Y

SS10

IV

Y

c

Y

SS118

I

Y

Y

SS55

I

Y

Y

SS106

V

N

Y

SS144

V

Y

c

Y

a b

, , and d summarize data as previously described (19, 20, 94, 134, 146). b Determined

by reactivity with HSV-1 gB under native and denaturing PAGE conditions. c Detects a
small amount of gB after denaturing as described. d Defined as reducing HSV-1
infectivity. egB epitope reactivity was measured by dot blot as in Materials and Methods.
nd, not determined.
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Figure 6. gD

A) Domain arrangement of HSV-1 Patton strain gD. In green, yellow and red are the
regions that form the HVEM binding domain, the Ig-like core, and the C-terminal region
respectively. Disulphide bonded cysteines are indicated by numeration and are adjoined
by black lines. N-linked oligosaccharides are indicated as lollipops. TM is the
transmembrane region.

B) Ribbon representation of the gD(23–306)307C subunit. The structural elements are
labeled and color coded as in A.

C) Ribbon representation of a proposed gD dimer.
D) Surface rendering of a gD dimmer showing how inaccessible the profusion domain is
prior to binding. The right protomer is color coded as in A, the left promoter is shaded
gray for clarity.
(Image adapted with permission from the publisher (99)
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Table 3. Antibodies to specific regions of gD

Ab

Epitope type

Binding region

Neutralizing

1103

Continuous

1-23

yes

DL11

Discontinuous

1-223

yes

DL2

Discontinuous

21-226

no

DL6

Continuous

272-279

yes

R7

Polyclonal

N/A

yes

Data from references (37, 55, 85, 115, 121).
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Figure 7. HSV-2 gH-gL
A) Domain arrangement of gH and gL. gH domains are colored green (H1), yellow (H2)
and red (H3). gL is colored blue. Structurally un-resolved regions are indicated as
dotted lines. Disulphide bonded cysteines (designated C) are numbered and joined by
black lines.
B) A ribbon rendering of the structure colored as in A.
C) Surface rendering of the gH-gL structure. Heel, sole, and toe domains are indicated
with the corresponding domains.
(Image reproduced with permission from the publisher (34)
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Virus induced membrane fusion.
Viral fusion glycoproteins drive membrane fusion through conformational changes.
Conformational changes are triggered by host cell cues (185). Triggers are proteolysis,
receptor interaction, and the most common of all, low pH. Triggering can be a multi step
process such as via sequential interaction with receptor and then co-receptor (HIV).
Receptor binding followed by encountering low pH or proteolysis may also occur (137,
185).
The energy for membrane fusion is provided by conformational changes (Figure
8). Upon encountering their trigger, fusion glycoproteins undergo conformational
changes that enable insertion of part of the fusion peptide into the host membrane.
These regions are usually apolar and contain several bulky hydrophobic residues.
Insertion causes deformation of the host membrane. There then follows collapse of the
fusion intermediate into a postfusion conformation. This brings the membranes into
proximity. The two membranes fuse and a pore forms. This pore expands until the viral
cargo is released into the cytoplasm (53, 180, 185).
There are several distinct classes of fusion glycoprotein. Class I and II differ in
the composition of their secondary structure, and in their prefusion oligomeric makeup.
Class III fusion glycoproteins are similar to Class I in that they have large coiled coil
regions and are trimeric in the prefusion conformation. Class III fusion glycoproteins
have large β-sheet motifs including fusion loops reminiscent of those found in Class II
fusion proteins. In addition, Class III fusion glycoproteins differ from both other classes
in that they are able to reverse conformational changes once triggered (53, 180, 185).
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Figure 8. Model of viral fusion glycoproteins fusion inducing
conformational changes
A) Glycoprotein is in a metastable prefusion conformation.

B) Upon encountering their trigger (low pH is indicated), fusion glycoproteins undergo
conformational changes that enable insertion of part of the fusion peptide into the host
membrane. An extended intermediate conformation is cartooned.
C) There then follows collapse of the fusion intermediate into a postfusion conformation.
The two membranes fuse and a pore forms. The viral cargo is released into the
cytoplasm
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The aim of this study
Much progress has been made over the last several years in understanding HSV
entry into the host cell. However, the precise triggers of membrane fusion during virus
entry remain to be determined.
The overall goal of this study is to define the role of low pH during the endocytic
entry of HSV. In the first section, studies were designed to define precisely where low
pH is acting in HSV entry. Having identified HSV gB as being triggered for fusion by low
pH, the second section further characterizes conformational changes in gB. Studies are
also designed to give insight into the mechanism of fusion. The third section examines
conformations of gB throughout synthesis, processing and incorporation into the virion.
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II. Materials and methods

Cells and viruses
Vero cells (American Type Culture Collection; ATCC; Rockville, Md.) and Cos-7
cells (provided by Shirley Taylor, Virginia Commonwealth University) were propagated
in Dulbecco’s Modified Eagle’s Medium (DMEM; Invitrogen, Grand Island, NY)
supplemented with 10% fetal bovine serum (FBS; Gemini Bio-Products, West
Sacramento, Calif.). CHO-nectin-1 cells were propagated in Ham's F12 medium (Life
Technologies, Grand Island, N.Y.) supplemented with 10% fetal calf serum (FCS; Life
Technologies), 150 µg of puromycin (Sigma, St. Louis, Mo.)/ml, and 250 µg of Geneticin
(Life Technologies)/ml. Cells were subcultured in nonselective medium prior to use in all
experiments.
HSV-1 strain KOS (provided by Priscilla Schaffer, Harvard University) and HSV-2
strain 333 (provided by Stephen Straus, National Institutes of Health) were propagated
and titered on Vero cells.

Antibodies
The biochemical characteristics of the antibodies used in this study are
summarized in Tables 1 and 2 from (19, 20, 37, 55, 85, 94, 115, 121, 134, 146). In brief,
the DL series of antibodies was raised against BHK cell extracts infected with HSV 1
and 2. The H series were isolated form mice immunized with HSV-1 14012 strain. R
series were generated from rabbits immunized with purified HSV glycoproteins. SS and
RC were generated by challenging mice with gB from HSV 1 and 2 that had been
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purified from cell extracts (DL16 column), portions of which were native in conformation,
alkylated or reduced.

Purified proteins
The following are a list of the purified proteins used throughout with explanation
of their acquisition and relevant construction details.
Ovalbumin, purified grade-V (obtained from Sigma A5503), (Gallus gallus
ovalbumin) contains 3 tryptophans and is 386 amino acids in length. This is purified
from chicken hen egg whites.
gC, was gC1(457t) described in (171). gC from HSV-1 KOS is truncated at
amino acid 457, 18 amino acids before its transmembrane region. This is expressed
from recombinant baculoviruses in Sf9 cells. This construct has 8 tryptophans.
gD-2t, was obtained from Stephen Straus (41). This is gD from HSV-2 333 that
has only its transmembrane region deleted and retains its C-terminal tail. The exact
amino acid sequence is unclear in the literature. It was reported to be “constructed in a
fashion similar to that reported by Stuve (87, 168). gD-2t was expressed in CHO cells.
This is predicted to contain 6 tryptophans.
gD(Δ290-299t). First described in Nicola 1996 (128), gD-1(290-299t) has amino
acids 290 to 299 deleted, R replacing I at residue 290, and amino acids KIFL inserted
after R. It has 6 tryptophans and is 389 amino acids in length. This is expressed from
recombinant baculoviruses in Sf9 cells.
s-gB (obtained from Stephen Straus). The gB2ΔTM construct contains the
following amino acids of gB from HSV-2 strain 333 (numbered per (168)
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Ala23 to Asn725 fused to Gln799 to Leu904 (Ala726 to Leu798 are deleted). The
deletion includes the transmembrane region based on Chou and Fasman (Ala745 to
Leu798) (189). It is 809 amino acids in length. This was expressed from a recombinant
construct in CHO cells.
gB730 (obtained from Roselyn Eisenberg, Gary Cohen). Described in (20), this
contains amino acids 31 to 730 of HSV KOS gB. It is truncated prior to the
transmembrane and tail region. gB730 is 700 amino acids long and contains 7
tryptophans. This is expressed from recombinant baculoviruses in Sf9 insect cells.
HVEMt, was originally described in (182) as HVEM(200t), HVEMt contains
amino acids 39-200 of HVEM. The first 38 amino acids are a signal sequence that is
cleaved during synthesis. Amino acid 200 is just before the transmembrane region and
was truncated to increase solubility of the construct. This is expressed from recombinant
baculoviruses in Sf9 insect cells.
Nectin-1t, was originally described in (98) as HveCt. It contains amino acids 31346 of Nectin. The first 30 amino acids are a signal sequence that is cleaved during
synthesis. Amino acid 346 is just before the transmembrane region and was truncated
to increase solubility of the construct. This is expressed from recombinant baculoviruses
in Sf9 insect cells.

Luciferase reporter assay for cell-cell fusion
Cos-7 (effector) cells were grown in 6-well plates and transfected with plasmids
encoding T7 RNA polymerase (pCAGT7), gB (pPEP98), gD (pPEP99), gH (pPEP100),
and gL (pPEP101) (135) obtained from G. Cohen and R. Eisenberg. For experiments
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with multiple glycoproteins, 0.8 µg of each glycoprotein-encoding plasmid was
transfected per well. For experiments with single glycoproteins 3.0 µg of each
glycoprotein encoding plasmid or empty vector was transfected with 0.8 µg of pCAGT7.
Transfections were performed using Lipofectamine 2000 (Invitrogen). To prepare target
cells, Vero cells in six-well plates were transfected with 2.0 µg per well of plasmid
encoding the firefly luciferase gene under control of the T7 promoter (pT7EMCLuc).
Cells were trypsinized, pelleted and resuspended in culture medium. Target and
effector cells were mixed, plated in 24-well plates and incubated at 37°C overnight.
Cells were then washed with PBS, incubated for 2 min in buffered pH medium (5 mM
(each) HEPES (Life Technologies), 2-(N-morpholino)ethanesulfonic acid (MES; Sigma),
and sodium succinate (Sigma), washed in PBS and incubated at 37°C. A second 2 min
pH treatment was repeated at 3 hr. At 7 hr post-pH treatment, cells were washed with
PBS and lysed (Luciferase Assay System; Promega). Lysates were mixed with
substrate (Promega) and immediately assayed for light output using a Tropix TR717
microplate luminometer (Perkin Elmer). Assays were performed in triplicate and
repeated at least three times for each experiment.

Confocal microscopy of virion gB during viral entry
CHO-nectin-1 cells were mock-treated or treated with 25 nM bafilomycin A1 for
15 min. HSV-1 KOS (MOI of 20) was bound to cells at 4oC for 1 hr. Cultures were
shifted to 37oC for 1 hr in the constant presence of BFLA or vehicle control, and 0.5 mM
cycloheximide. Cells were fixed with 3% paraformaldehyde (Thomas Scientific) and
permeabilized with 0.2% Triton X-100 (Fisher Scientific). Virion gB was detected with 2
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mg/ml MAb H126 or 0.5 mg/ml MAb H1817 (Virusys) followed by Alexa 488-labeled
goat anti-mouse antibody. Samples were visualized with a Zeiss LSM 510 Meta
microscope equipped with a 63x oil immersion objective lens. 50 to 70 cells are shown
per panel.

Confocal microscopy of gB in the infected cell
Vero cells were infected with HSV-1 KOS at an MOI of 5. At 1 hours post
infection cells were treated or mock treated with 25nM Bafilomycin-A1. At 6.5 hr p.i.
cells were fixed with 3% paraformaldehyde and permeabilized with 0.2% Triton X-100.

Pulse chase
Vero cells were infected with HSV-1 KOS (MOI 5) for 6 hrs. Cells were washed in
PBS, then medium was replaced with DMEM without cysteine or methionine
(Invitrogen). After 20 minutes medium was replaced with DMEM containing 400 µCi of
radiolabled cysteine and methionine (MP Biomedicals) for a 100 second pulse. To
chase samples, DMEM with 20 mM HEPES, 5 mM L-cysteine, 5 mM L-methionine and
1 mM cycloheximide was added, then washed, and replaced a final time. To stop,
samples were moved to ice and media was replaced with ice-cold PBS containing 20
mM N-ethylmaleimide (NEM). Samples were lysed with ice-cold 2% CHAPS in HBS
containing 20 mM NEM and protease inhibitors (Roche). Samples were then
immunoprecipitated over night using Pro-A agarose with an excess of the indicated
antibody. gB was visualized using SDS-PAGE and autoradiography.
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Antigenic conformation of virion gB vs. gB in infected cells
HSV gB from virions or from cell lysates was immunoprecipitated with specific
anti-gB antibodies, MAbs H1817, SS10 and H126 are shown. Samples were analyzed
by SDS-PAGE and Western blotting.

Triton X-114 partitioning
To increase the association of hydrophobic gB with the amphiphilic (pellet)
phase, Triton X-114 (Fisher Scientific) was preconditioned to reduce the amount of the
most hydrophilic Triton X-114 molecules and to enrich for the amphiphilic molecules. To
precondition, the hydrophilic phases from each of three overnight condensation steps
was discarded (24). Condensation was performed at 30oC. 200 ng of s-gB, gB730, gD2t , gD-1(290-290t), or 20 µg of BSA were incubated with preconditioned 2% Triton X114 in fusion medium buffered (MES, Succinate and HEPES as previously mentioned)
to various pHs on ice for 10 min. Samples were incubated at 37oC for 10 min, and then
pelleted at 25˚C for 3 min at 300 x g. Aqueous and pellet phases were collected and
either immunoprecipitated with MAb H1359 (gBs), DL6 (gDs) or precipitated with
trichloroacetic acid (BSA).

Sucrose density centrifugation
Extracellular virions were lysed in 1% Triton X-100 for 30 min at room
temperature and layered onto a step gradient of 8%-60% (wt/wt) sucrose in 20 mM
each of MES, sodium succinate and HEPES, 175 mM NaCl, 2.5 mM EDTA, 2.5 mM

46

EGTA, and 1% Triton X-100. Indicated pHs were adjusted by adding HCl. Samples
were sedimented at 40,000 rpm for 16 h at 4°C in a Beckman SW41 rotor. Fractions
were collected, immunoprecipitated with MAb H1817 (Virusys), and analyzed by SDSPAGE followed by immunoblotting with MAb H1359 to gB (Virusys).

Dot blot analysis
s-gB, gB730 or cell-free preparations of extracellular HSV-1 KOS were diluted in
serum-free, bicarbonate-free DMEM with 0.2% bovine serum albumin (BSA) and 5 mM
(each) HEPES (Life Technologies), 2-(N-morpholino)ethanesulfonic acid (MES; Sigma),
and sodium succinate (Sigma) to achieve final pHs ranging from 7.4 to 4.8. Samples
were incubated at 37°C for 10 min. Samples either were blotted directly to nitrocellulose
with a Minifold dot blot system (Whatman) or were first neutralized by addition of
pretitrated amounts of 0.05 N NaOH. For detection of gB, membranes were blocked and
incubated with anti-gB monoclonal antibody H126 (94), H1359, H1817 (134) (Virusys),
DL16, SS10, SS55 (20), SS106, SS144 (19) or R69 polyclonal antibody to gB provided
by G. Cohen and R. Eisenberg. For detection of gD, anti-gD antibodies R7, DL2, DL6
1103 and DL11 (37, 55, 85, 115, 121) were incubated with membranes. After incubation
with horseradish peroxidase-conjugated secondary antibodies, enhanced
chemiluminescent substrate (Pierce) was added and membranes were exposed to X-ray
film (Kodak).
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Analysis of gB oligomeric structure by PAGE
HSV-1 KOS virions, HSV-2 333 virions, infected cell lysates, or a recombinant
soluble form of gB (s-gB) was diluted in medium as described above for dot blotting. sgB has the transmembrane domain deleted (gB-2t) (189) and was obtained from
Stephen Straus. Samples were adjusted to the indicated pHs with pretitrated amounts of
0.05 N HCl and incubated at 37°C for 10 min. SDS (1%) was added, or samples
remained untreated. Polyacrylamide gel electrophoresis (PAGE) sample buffer
containing 0.2% sodium dodecyl sulfate (SDS) and no reducing agent was added
("native" conditions), and proteins were resolved by PAGE (37). After transfer to
nitrocellulose, membranes were blocked and incubated with rabbit polyclonal antibodies
specific for gB, gC, gD, or gH-gL (provided by G. Cohen and R. Eisenberg). After
incubation with horseradish peroxidase-conjugated secondary antibodies, enhanced
chemiluminescent substrate (Pierce) was added, and membranes were exposed to Xray film (Kodak).

Clustal W alignment
The sequences of HSV KOS gB, gB730, HSV-333 gB, and s-gB were compared
using Multiple Sequences Alignment tool “Clustal W” from EMBL. A full alignment was
performed using the default settings.
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Intrinsic fluorescence
300-600 ng of purified protein were diluted in 30 µL in Hypure H2O (Fisher)
containing 137 mM NaCl, 5 mM (each) HEPES (Life Technologies), MES (Sigma), and
sodium succinate (Sigma) to achieve final pHs ranging from 7.3 to 5.1. The minimal
detectable concentration of each protein varied slightly due to the number and
environment of fluorescent amino acids present. Proteins were incubated at 37oC for 2
min and fluorescence was measured at room temperature using a Shimadzu RF5301PC Spectroflurophotometer (thanks to John Hackett, Darrell Peterson, VCU
Department of Biochemistry for use of equipment). Excitation was performed at 280 nm.
A 10 nm spectral bandwidth was used with a 0.5 s response time. Emission was
recorded over 310-400 nm. Data was processed using Microsoft Excel. To test the
reversibility of conformational changes, samples were prepared at pH 5.1, incubated for
2 minutes, and then neutralized with a pre-determined amount of NaOH. Samples were
then incubated at 37oC for 30 seconds and fluorescence was measured. Nonneutralized samples had H2O added in place of NaOH although this did not alter the
shift in peak emission observed.
All proteins except for gD-2t (explained in results) had similar patterns of low pH
induced emission shift at higher and lower concentrations.
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Soluble gD binding ELISA
Soluble receptors HVEMt (15 µg/ml) or nectin-1t (10 µg/ml) in PBS were bound
to microtitre plates overnight at 4 ˚C. Plates were incubated with 1% BSA and 1%
chicken egg albumin (Sigma) in PBS (blocking buffer) for 1 hr at room temperature.
Dilutions of gD(Δ290-299t) that had been treated with a buffer of pH 4.7 for 10 min at 37
˚C, heated to 80˚C for 10 min, or mock treated, were prepared in blocking buffer and
were added for 3 hr at room temperature. Anti-gD MAb DL6 in blocking buffer was
added for 1 hr at room temperature. Protein A-peroxidase (Roche Diagnostic) in
blocking buffer was added for 1 hr at room temperature. 2,2’-azinobis(3ethylbenzthiazolinesulfonic acid (Pierce) substrate was added.

HSV gB fusion loop mutations
Our collaborators at the laboratory of David Johnson kindly provided cell-associated
virus preparations of fusion loop mutant viruses.
In brief, the mutant viruses were generated as follows (74, 179, 192);
Mutant gB constructs were made in plasmid pPEP98 using a QuikChange site-directed
mutagenesis kit (Stratagene Cloning Systems, La Jolla, CA). Primers were designed to
mutate the gB gene to encode the specified amino acid sequences (sequence not
detailed in literature). Mutations were performed by amplifying pPEP98 DNA with
mutant generating PCR primers in PCR reactions. Sequencing of the entire gene
confirmed the desired mutations. Insertion of mutant and wild type genes into the HSV-1
strain F BAC was done via galK recombination. For BAC mutagenesis, gB from mutant
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or parental plasmids were excised with XhoI and BglII, and purified (QIAquick gel
extraction kit (Qiagen, MD). DNA was transformed into SW102 bacteria containing the
HSV-1 F strain BAC designated BAC-gBgalK/gH. BAC-gBgalK/gH has a kanamycin
cassette in place of the glycoprotein H gene, and galK encoding sequence replacing gB.
Temperature-sensitive lambda prophage recombination proteins induced
recombination. Homologous regions between the mutant gB DNA and the flanking
regions in the BAC sequence were predicted to undergo recombination. Selection was
performed on M63 agar plates containing glycerol (0.2%; Fisher), d-biotin (1 mg/l), lleucine (45 mg/l), 2-deoxy-galactose (0.2%; Ferro Pfanstiehl) and chloramphenicol
(12.5 µg/ml). Bacteria containing BACs that retain the galK sequences metabolize 2deoxy-galactose and accumulate a toxic build up of 2-deoxy-galactose-1-phosphate
(Nucleic Acids Res. 2005 Feb 24;33(4):e36). Colonies that grew were believed to have
replaced galK with the desired gB sequence were screened by sequencing. Clones that
contained the desired sequences were grown and had DNA prepared via plasmid
maxikit (Qiagen, MD). BAC DNA was then transfected into Vero derived F6 cells that
express gH. Transfection was via the lipid reagent, TransFectin (Bio-Rad, Hercules,
CA). The resulting HSV viruses were propagated and tittered in F6 cells. Cell
associated virus preps were made by infecting Vero (wt) or gH complimenting F6 cells
(mutants with ΔgH) for 18hrs. Cells were then scraped into tubes and freeze thawed
three times. large cell debris was removed by pelleting twice. gB assays were
performed for viruses from the BAC-gBgalK/gH background with no gB (w.t.gB/gH-),
with KOS gB (gBgalK/gH-), with the fusion loop 1 mutation Y179K (Y179K) and a fusion
loop 2 mutation (A261D).
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DEPC treatment of HSV
Virions of HSV KOS were concentrated and resuspended in PBS. 50ug of virus
was treated with the DEPC concentration indicated for ten minutes at room
temperature. Infectivity was then analyzed in the indicated cell types via βgalactosidase reporter assay (CHO derived cells) or plaque assay (Vero and HaCaT).
DEPC concentration was determined from the increase in absorbance at wavelength
230 due to conversion of imidazole to N-carbethoxy imidazole and its molar extinction
coefficient 3200.

β-galactosidase reporter assay
Confluent cell monolayers grown in 96-well dishes were infected with HSV (strain
KOS) at an MOI of 5. Infected cells were incubated at 37°C for 6 h. Cells were lysed in
0.5% Nonidet P-40, chlorophenol red-β-D-galactopyranoside (Roche Diagnostics) was
added, and β-galactosidase activity was determined by absorbance at 560 nm using a
microtiter plate reader (Dynatech, Chantilly, Va.). Mean results were calculated for four
replicate samples. The β-galactosidase activity from infected but mock-treated cells
was defined as 100%.

HSV plaque assay
Confluent cell monolayers grown in 24-well plates were infected with serially
diluted HSV-1 KOS. Infected cells were incubated at 37°C for 18 h and fixed in
methanol. Visualization of plaques was aided by antibody detection and HRP
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conversion of 4-chloro-1-naphthol to a blue/black color on the monolayer. Mean plaque
number calculated from 4 wells is shown.
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III. Identifying a role for pH in the endocytic entry of HSV

Mildly acidic pH promotes cell fusion mediated by HSV glycoproteins
Intracellular low pH is required for the cell entry of several herpesviruses, often in
a cell type specific manner. The precise role of low pH in herpesviral entry is not clear.
A luciferase reporter assay of cell-cell fusion was employed to investigate a direct,
activating role of low pH in fusion mediated by HSV glycoproteins. Cells that transiently
express the glycoproteins gB, gD, gH and gL fuse with target cells (135, 176) (Figure
9A). Thus, fusion mediated by glycoproteins expressed on the cell surface can occur at
pH 7.4. When effector and target cells were mixed, allowed to interact, and then pulsed
twice with culture medium of pH 6.0, there was an increase in cell-cell fusion mediated
by gB, gD, and gH-gL (Figure 9A). This suggests that low pH has a stimulatory effect
on the fusogenic activity of one or more HSV glycoproteins. Experiments where an
individual glycoprotein was substituted with vector (vector, gD and gH-gL is shown)
indicate that for optimal fusion in a low-pH environment, gB, gD and gH-gL are
essential.
We examined the effect of a range of pH on glycoprotein-mediated fusion (Figure
9B). There was an increase in cell-cell fusion when cells were treated at decreasing
pHs. Maximal fusion was reproducibly detected at pH 6.0 to 5.7. Intravesicular pH
along the lysosome terminal endocytic pathway pH ranges from ~ 6.2 in early
endosomes to ~ 4.8 in lysosomes (113). Thus, the pH optimum of cell-cell fusion is
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within the range of pH found in endosomes. Control treatment of cells with pHs 7.4 to
4.7 did not affect luciferase production when both reporter components had been
transfected into the same cell types (data not shown).
The effect of acidic pH on fusion mediated by the individual glycoproteins was
assessed. Treatment with pH 6.0 enhanced the fusogenic activity of gB on its own
(Figure 9C and 9D). The extent of fusion depended on the amount of gB plasmid used
for transfection . There was little increase in fusion mediated by gD or gH-gL alone
(Figure 9C). Fusion mediated by the four glycoproteins at pH 7.4 measured in relative
light units was reproducibly greater than the pH-triggered fusion by gB alone (data not
shown), consistent with the requirement of all four glycoproteins for optimal fusion and
entry. Cell monolayers transfected with gB or gD have been reported previously to
undergo pH-dependent cell fusion as detected by light microscopy (2, 26). We cannot
rule out the possibility of pH effects on the structures and functions of gD and gH-gL.
Since mildly acidic pH had the greatest effect on gB function, we pursued the effect of
pH on gB in greater detail.
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Figure 9. Effect of Low pH Treatment on HSV Glycoprotein-Induced
Cell-Cell Fusion.
Cos-7 effector cells were grown and transfected with plasmids encoding T7 RNA
polymerase and glycoproteins. Target Vero cells were transfected with a plasmid
encoding the firefly luciferase gene under control of the T7 promoter (pT7EMCLuc).
After 5 h target and effector cells were mixed, plated in 24-well plates and incubated at
37°C overnight. Cells were pulsed twice with pH media buffered and incubated for 9 hrs
to allow luciferase expression.
(A) Cos7 cells expressing gB, gD, gH, gL or vector as indicated were mixed with Vero
cells and treated with the indicated pHs. Luciferase activity measured in Relative Light
Units (RLU) and expressed as a percent of luciferase activity from samples with gB, gD,
and gH-gL at pH 7.4.
(B) Fusion mediated by gB, gD, and gH-gL over a range of pH is shown
(C) Fusion induced by the individual HSV glycoproteins at pH 7.4 and 6.0 is shown.
More than three times the DNA was used for transfection relative to gB, gD, gH-gL (A).
(D) Fusion mediated by gB over a range of pH is shown.
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Low-pH treatment alters the exposure of epitopes in the fusion
domain of virion gB
Viral glycoprotein-mediated fusion is accompanied by conformational changes
that result in domain rearrangement and exposure of hydrophobic fusion peptide
sequences. The hydrophobic peptide then interacts with lipids of the target membrane,
which is an essential destabilizing step in the fusion process (185).
To begin to determine whether intracellular low pH directly causes
conformational change in gB associated with fusion and entry, we measured the
reactivity of mouse monoclonal antibody (MAb) H126. H126 has complementindependent, virus-neutralizing activity and recognizes a linear epitope in the putative
fusion domain of gB (domain I) (78, 94, 132, 146). In addition, a fusion-from-without
form of virion gB with enhanced fusogenicity was shown to have an H126 epitope with
altered accessibility (146).
HSV virions were exposed to pHs ranging from 7.4 to 4.8 and were immediately
blotted to nitrocellulose membranes. Antibody binding was then assessed at pH 7.4.
MAb H126 displayed diminished binding to virions that had been treated at pH <6.2
(Figure 10). Approximately 50% of H126 reactivity was lost in virions exposed to pH 5.9.
Similar results were obtained with an additional MAb to domain I, SS55 (Figure 10;
Table 4). This suggests a specific change in the antigenic structure of the fusion
domain. As a control, MAb H1817 to N-terminal residues 31 to 43 (domain VI) of gB
displayed unaltered binding to acid-treated virions (Figure 10). Similarly, MAbs H1359
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and SS10, directed to domains III and IV, respectively, and gB-specific polyclonal
antibody (PAb) R69, which also bound well to low pH-treated HSV (Figure 10; Table 4),
suggest that the structure of gB is not globally altered and that the detected changes in
reactivity are specific to domains I and V. Domains I and V are in close proximity and
together form a functional region (19). Interestingly, MAbs to domain V, SS106 and
SS144, had reduced binding to virions that had been treated with mildly acidic pH
(Figure 10; Table 4), similar to the domain I-specific antibodies. Together, the results
suggest that exposure of HSV to a pH of less than or equal to 6.2 changes the antigenic
conformation of the gB functional region 1 that contains fusion loops (74).
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Figure 10. Antibody reactivity of low pH-treated virions
Extracellular HSV-1 KOS virions (105 PFU) were treated for 10 min at 37°C with
medium buffered to the indicated pHs and were blotted immediately to a nitrocellulose
membrane. Blots were probed at neutral pH with the indicated gB-specific antibodies,
followed by horseradish peroxidase-conjugated goat secondary antibody. The exposure
shown for MAb H126 highlights the pH threshold of conformational change.
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Table 4. Summary of monoclonal antibodies to gB used in this study

Antibody

Domain

Conformation

Neutralizing

c

Reacts with low pH-treated gB

d

a

-dependent

DL16

nd

Y (Oligomer

HSV-1 KOS

s-gB

-

-

-

specific)
H126

I

N

+

-

-

H1359

III

N

-

+

+

H1817

VI

N

+

+

+

SS10

IV

Y

+

+

+

SS55

I

Y

+

-

-

SS106

V

N

+

-

-

SS144

V

Y

b

+

-

-

polyclonal

na

+

+

+

R69

b

Data in the first three columns have been previously described (19, 20, 94, 134, 146).
a

Y, reactive with HSV-1 gB under native PAGE conditions but not under denaturing

conditions. N, reactive under denaturing conditions only. bReactive with native gB and
with a small amount of gB under denaturing conditions (19). cDefined as reducing HSV1 entry or plaque formation. dgB epitope reactivity was measured by dot blot as in
Materials and Methods. nd, not determined; na, not applicable.
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Mildly acidic pH alters the oligomeric structure of gB
Viral fusion proteins are oligomers (185). HSV gB is oligomeric, and an
ectodomain form of HSV-1 gB has a trimeric structure (35, 78). Low pH-triggered
membrane fusion can be accompanied by rearrangement of viral glycoprotein oligomer
subunits (3, 178). Three approaches were used to determine the effect of acid pH on the
quaternary structure of gB. First, HSV virions were solubilized with the nonionic
detergent Triton X-100 and subjected to sucrose gradient centrifugation at pH 7.4 or pH
5.1. Fractions were analyzed by immunoprecipitation, SDS-PAGE, and immunoblotting
for gB. At pH 7.4, gB was detected in fractions that corresponded to >181 kDa in
molecular mass. This is consistent with gB oligomers and is similar to previous reports
(81). At pH 7.4, a peak in fraction 6 and a broad peak from fractions 8 to 11 were
observed (Figure 11A). In contrast, at pH 5.1, gB sedimented predominantly as a single
population at fractions 6 and 7, suggesting that low pH caused gB to shift from a higher
oligomeric form to a lower-density oligomer. Quantitation confirmed that the
sedimentation profile of virion gB at pH 5.1 had shifted to a single, less dense peak
(Figure11A bottom).
Second, a monoclonal antibody specific for oligomeric gB, DL16 (7), was
employed. HSV-1 KOS virions were treated with either pH 7.2 or 5.5 and blotted to
membranes, and the reactivity of MAb DL16 was evaluated at neutral pH. After
exposure to pH 5.5, there was a decrease in DL16 reactivity (Figure 11B). As a control,
rabbit polyclonal antibody to gB (R69) detected both virion samples to a similar extent.
Lastly, these results were extended by a direct analysis of virion gB by PAGE.
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Oligomers of HSV gB are comprised of noncovalently associated monomers. gB
oligomers are disrupted experimentally by a combination of SDS and heat (35),
resulting in monomeric gB that migrates at 116 kDa after SDS-PAGE. We tested
whether low pH had an effect on the detergent stability of the gB oligomeric structure.
Virions were adjusted to pHs ranging from 7.4 to 5.1 and prepared for "native" PAGE in
sample buffer containing 0.2% SDS without reducing agent and without heating. Under
these conditions, regardless of pH treatment, gB migrated as a range of oligomeric
species of >181 kDa (Figure11C, lanes 1 and 2). Treatment of HSV with pH 7.4
followed by 1% SDS yielded gB species of similar high molecular weight (Figure 11C,
lane 3), indicating that 1% SDS alone had no detectable effect on the gB oligomer. In
contrast, pretreatment with pH <6.4 followed by 1% SDS reduced the number of gB
species detected (Figure 2C, lanes 4 to 7). The highest-molecular-weight forms seemed
to disappear, leaving only a single detectable oligomeric species of lower molecular
weight (Figure 11C, lanes 6 and 7). This suggests that low pH alters the oligomeric
structure of gB, making it more sensitive to disruption by SDS. With decreasing pH,
there was an apparent decrease in detection of gB-reactive species. One explanation is
that monomers are detected only weakly relative to oligomers under standard native
PAGE analysis (data not shown). Alternately, upon activation by pH, gB may become
part of a larger complex that does not enter the native gel. For example, during fusion,
gB forms higher-molecular-weight complexes with gD and gH-gL (8, 19). Notably, the
total amount of gB detected by dot blot does not change upon exposure to mildly acidic
pH (Figure 10). Together, results from the three approaches (Figure 11A, B, and C)
suggest that low pH alters the oligomeric conformation of virion gB, resulting in a lower-
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order oligomer.
To address whether the >181 kilodalton gB-reactive bands shown in Figure 11C
were indeed oligomers of gB, we tested whether other HSV entry glycoproteins
comigrated with the gB-containing complexes. Virion gC, gD, gH, and gL at pH 7.4 each
migrated independently of gB under native PAGE conditions (Figure 11D, lanes without
1% SDS). gB may associate with other proteins. However, since a purified form of the
recombinant gB oligomer has a molecular weight similar to that of virion gB (see Figure
13A), we favor the interpretation that the high-molecular-weight species shown in Figure
11C represent gB homo-oligomers.
Treatment of virions with pH 5.1 did not affect the migration of gC, gD, gH or gL
relative to pH 7.4 on native polyacrylamide gels (Figure 11D, lanes without 1% SDS). In
addition, low pH did not reproducibly affect the detection of these glycoproteins,
including the gH-gL hetero-oligomer (Figure 11D, braces). Virion gC, gD, gH, or gL was
also not affected when subjected to the conditions that demonstrated the effect of low
pH on the detergent stability of gB (Figure 11D, lanes with 1% SDS). Based on these
analyses, gB may be the entry glycoprotein principally affected by pH.
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Figure 11. Effect of low-pH treatment on the oligomeric state of gB.
(A, top panel) Virions were solubilized with 1% Triton X-100 and subjected to
sedimentation through sucrose (8 to 60%) buffered to pH 7.4 or 5.1. gB was
immunoprecipitated from each collected fraction with MAb H1817 prior to SDS-PAGE
and immunoblotting with MAb H1359 for detection of gB. In parallel experiments, protein
standards were employed to approximate the range of molecular weights of proteins in
each fraction. (A, bottom panel) Results were quantitated by densitometry. (B) Binding
of gB oligomer-specific monoclonal antibody DL16 to low pH-treated virions. As
described in the legend to panel A, HSV-1 KOS virions were treated with pH 7.2 or 5.5,
and then 2-fold dilutions were blotted to a membrane. (C) Virions were treated with the
indicated pH, adjusted to 1% SDS where indicated, and then analyzed by PAGE and
immunoblotting with R69 to detect gB. (D) HSV-1 KOS virions were treated at pH 7.4 or
5.1, solubilized with 1% SDS where indicated, and then analyzed by native PAGE and
immunoblotting with polyclonal antibodies specific for gB, gC, gD, or gH-gL.
Glycoprotein-specific bands are indicated with the name of the protein. Nonspecific
bands that were detected in mock-infected, Vero cell-conditioned medium (not shown)
are indicated by asterisks. Protein molecular weight standards are indicated on the left.
, anti.
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pH-triggered conformational changes are reversible
Conformational changes in class I and class II fusion proteins are irreversible
(185). As an example, the prefusion form of hemagglutinin (HA) (class I) in the influenza
viral envelope exists in a metastable state. If it is triggered by low pH in the absence of
a target membrane, HA is irreversibly converted to the postfusion form and can no
longer mediate fusion with a subsequently presented membrane (184). In contrast,
conformational changes in the class III fusion protein VSV-G are reversible, with
prefusion and postfusion forms existing in a thermodynamic equilibrium (67, 141). The
equilibrium is shifted toward the postfusion state at low pH. It is believed that class III
fusion glycoproteins undergo reversible conformational changes to allow them to remain
fusogenic as they encounter the low-pH of the trans-Golgi network. To investigate the
reversibility of changes in gB, we again assayed the effect of 1% SDS on oligomer
stability using native PAGE (Figure 11C). KOS virions were incubated at pH 5.1, reneutralized to pH 7.4, and then 1% SDS was added (Figure 11C, lane 8). Oligomeric
forms of gB were detected (Figure 11C, lane 8), indistinguishable from those of gB that
had been kept at neutral pH (lane 3). This suggests that low pH-induced changes in the
oligomeric structure of gB are reversible.
To extend the findings of reversibility, we tested whether pH-induced antigenic
changes were reversible, using a modification of the dot blot approach on HSV virions.
pH 5.5-treated HSV that was blotted to nitrocellulose displayed decreased reactivity with
MAb H126, relative to pH 7.2 treatment (Figure 12). Although this is an overexposure,
the reduction in H126 reactivity is consistent with the results shown in Figure 10.
However, when virions were treated first at pH 5.5 and then adjusted back to pH 7.2
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prior to being blotted, H126 reactivity was partly recovered. Similar results were
obtained with the oligomer-specific MAb DL16 (Figure 12), supporting the notion of
reversibility. Control polyclonal antibody to gB R69 reacted similarly with HSV that had
been subjected to each of the different pH conditions (Figure 12). Immobilization of
acid-treated virions on nitrocellulose membranes may limit the reversibility of alterations
in gB. This would explain why several of the MAbs to gB have diminished reactivity with
acid-treated HSV after it is bound to nitrocellulose (Figure 10 and Table 4).
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Figure 12. Reversibility of pH-induced conformational changes in gB
Extracellular HSV-1 KOS virions were treated with medium buffered to pH 7.2 or 5.5.
For the indicated samples, pH was neutralized back to 7.2 for 10 min at 37°C. Twofold
dilutions were blotted immediately to nitrocellulose membranes. Membranes were
probed at neutral pH with antibody H126, DL16, or R69, followed by the appropriate
horseradish peroxidase-conjugated secondary antibody.
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Acid pH alters the conformation of a soluble, recombinant form of gB
Thus far, pH-triggered changes have been detected in virion gB in the context of
the HSV envelope, which includes the other glycoproteins. gB, gD, and gH-gL likely act
together during membrane fusion. To address whether changes specific to gB could be
observed in the absence of other virion components, purified gB in isolation was
evaluated. We utilized a soluble form of gB (s-gB) from HSV-2 strain 333 (189). gB
molecules from HSV-1 KOS and HSV-2 333 are 86% identical. In this form of gB, the
transmembrane domain has been deleted, and the cytosolic tail is fused directly to the
ectodomain. s-gB is secreted and purified from CHO cells (168, 189). It migrates as an
oligomer on native PAGE (Figure 13A), binds to cell surface glycosaminoglycan
receptors (189), and reacts with all monoclonal antibodies tested, including the
oligomer-specific antibody DL16 (Figure 13A; Table 4).
Treatment of s-gB with mildly acidic pH followed by 1% SDS affected its
oligomeric conformation (Figure 13B). A pH of 5.1 converted oligomeric s-gB into a
monomer (Figure 13B). Conversion to a monomer began at pH <6.3 and was complete
by pH 5.9 (Figure 13C). Thus, the quaternary structure of purified gB was altered by the
same range of mildly acidic pH as that of gB that is present in the viral envelope
(compare Figure 13C and 11C). Acid-induced changes in s-gB were reversible (Figure
13B, center). Low-pH treatment converted gB present in HSV-2 333 virions into a lowermolecular-weight oligomeric form (Figure 13B, right), similar to the result obtained with
HSV-1 KOS gB (Figure 11C). Interestingly, this contrasts with the acid-dependent
conversion of the s-gB oligomer into a monomer. The difference may be due to the
absence of a membrane anchor or the absence of interaction with gD or gH-gL.
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Nonetheless, low pH affects the oligomeric structures of both purified gB and virion gB.
The reversibility of changes to both forms of gB is further demonstrated in Figure 13A.
Samples that were treated with pH 5.4, re-neutralized to pH 7.2, and then analyzed by
native PAGE migrated as oligomers, similar to the migration of samples that were not
exposed to low pH (Figure 13A). The change induced by pH 5.4 that was noted using
other approaches was likely reversed prior to sample loading. Lastly, s-gB that was
treated with acidic pHs and was then bound to nitrocellulose had a pattern of reactivity
with MAbs similar to that of pH-treated virion gB (Table 4), indicating that pH directly
triggers specific changes in gB antigenic structure. In total, the results suggest that gB
need not be present in a membrane, nor does gD, gH, gL, or any other viral component
need to be present in order for the observed pH-dependent changes to take place. In
the context of the virion interacting with the host cell membrane during fusion, additional
changes in gB likely occur that are not apparent in the current experiments.
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Figure 13. Effect of low-pH treatment on the conformation of purified
gB
(A) HSV-1 KOS virions (105 PFU) or s-gB (150 ng) in serum-free medium with 0.2%
BSA were kept at pH 7.2 or adjusted to pH 5.5 for 10 min at 37°C with 0.05 N HCl. The
pH of acidified samples was re-neutralized to 7.2 with 0.05 N NaOH for 10 min at 37°C.
Samples were analyzed by native PAGE and immunoblotting with gB-specific PAb R69
or MAb DL16. (B) Soluble gB derived from HSV-2 strain 333 (s-gB) was treated with pH
7.4 or 5.1 and then solubilized with 1% SDS either before or after neutralization of pH
(as described in the legend to Figure 11C). HSV-2 strain 333 virions were also treated
at pH 7.4 or 5.1 and solubilized with 1% SDS. (C) s-gB was treated with a range of pH,
as indicated, and then solubilized with 1% SDS. Samples were analyzed by PAGE and
immunoblot detection with R69 (gB).
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Low pH increases the hydrophobicity of gB
Conformational change associated with fusion is often accompanied by transient
exposure of hydrophobic regions, namely fusion peptides or fusion loops. To begin to
address whether conformational changes have an activating effect on gB, we used the
nonionic detergent Triton X-114 and s-gB. Upon centrifugation at room temperature,
Triton X-114 can be separated into hydrophilic (aqueous, top) and amphiphilic
(detergent, bottom) phases (24). Protein forms that are more hydrophobic associate
with hydrophobic Triton X-114 molecules and partition with the amphiphilic phase. This
approach was used to define pH-induced changes in alphavirus fusion glycoproteins
(92).
Purified s-gB that was treated at pH 7.4 was mixed with Triton X-114 at 37°C.
The mixture was centrifuged, and water-soluble gB was recovered from the aqueous
phase (Figure 14), where hydrophilic proteins are expected to partition. Little to no gB
was detected in the detergent phase, suggesting little hydrophobic interaction of gB with
Triton X-114. In contrast, as a result of treatment with pH 5.9 or 5.1, a fraction of the
total gB partitioned in the detergent phase (Figure 14), suggesting that low pH caused
gB to become more hydrophobic. As a control, low-pH treatment of bovine serum
albumin did not alter its hydrophobic character (Figure 14). The results are consistent
with the hypothesis that pH results in exposure of hydrophobic regions in gB. This
increase in hydrophobicity may correlate with changes in gB conformation, such as
alterations in oligomeric structure, and with activation of entry.
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Figure 14. Effect of low-pH treatment on the hydrophobicity of gB
Soluble gB or BSA was added to 2% Triton X-114 that had been adjusted to the
indicated pH. Samples were incubated for 10 min at 37°C and were centrifuged at 300 x
g for 3 min. The aqueous supernatant phase and detergent phase were collected and
diluted 20-fold in PBS. s-gB samples were subjected to immunoprecipitation with
antibody to gB, followed by SDS-PAGE and immunoblotting for gB. BSA samples were
trichloroacetic acid (TCA) precipitated and analyzed by SDS-PAGE and Coomassie
blue staining.
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Intracellular low pH affects the H126 epitope of virion gB during viral
entry
The kinetics of the distinct steps in the endocytic entry pathway of HSV have
been delineated in CHO-nectin-1 cells (127). Endocytic internalization of HSV from the
CHO cell surface has a half-life (t1/2) of 9 min. Enveloped virions are trafficked
through cellular compartments for up to 30 min postinfection (p.i.). Penetration of
>50% of infectious virions from a low-pH compartment (virus-cell membrane fusion)
occurs by 60 min p.i (127). To probe the exposure of the H126 epitope on gB during
endocytic entry of HSV, CHO-nectin-1 cells were infected with HSV-1 for 1 h, and input
gB was monitored by immunofluorescence and confocal microscopy. The early time of
infection analyzed and the addition of cycloheximide ensured that the signal detected
was due to input gB and not to the newly synthesized gB. gB that was brought into the
cell with entering virions was detected by MAb H126 as punctate staining (Figure 15).
Bafilomycin A1 (BFLA), a vacuolar H+ ATPase inhibitor that prevents endosome
acidification, inhibits HSV entry into CHO-nectin-1 cells (125). When infection
proceeded in the presence of BFLA, there was a detectable and reproducible increase
in the H126-reactive gB detected (Figure 15). As a control, MAb H1817 recognized
input intracellular gB to a similar extent in the absence or presence of BFLA (Figure 15).
This suggests that the N terminus of gB is accessible to antibody, even after exposure
to Intravesicular low pH. In contrast, the H126 epitope in domain I appears to be altered
during viral entry upon exposure to acidic pH. This change may be detected because all
virion gB molecules are exposed to endosomal low pH, regardless of whether they are
directly involved in viral entry.

79

Figure 15. Effect of bafilomycin A1 on the conformation of HSV gB
during viral entry
CHO-nectin-1 cells were mock treated (left) or treated with 25 nM bafilomycin A1 (right,
+BFLA) for 15 min. HSV-1 KOS (MOI of 20) was bound to cells at 4°C for 1 h. Cultures
were shifted to 37°C for 1 h in the constant presence of BFLA and 0.5 mM
cycloheximide. Virion gB was visualized with MAb H126 or MAb H1817 followed by
Alexa 488-labeled goat anti-mouse antibody. Samples were visualized by confocal
microscopy at 63x magnification. A total of 50 to 70 cells are shown per panel.
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Discussion
We demonstrate that conformational change in the fusogenic herpesviral
glycoprotein gB is triggered by the mildly acidic pH that is typically encountered in the
endosomal network (pH 5.0 to 6.0). Low pH specifically alters the antigenic structure
and oligomeric conformation of gB. Both conformational change and an increase in the
hydrophobic character of gB occur at a similar pH range. This work describes a critical
feature of the complex molecular mechanism of herpesviral entry by pH-dependent
endocytosis, a pathway that is employed by HSV in biologically relevant cell types,
including epithelial cells.
MAb H126 has HSV-neutralizing activity (94). The H126 epitope in the fusion
domain of gB becomes less accessible upon exposure of gB to low pH both in vitro and
during viral entry. Thus, H126 may neutralize virus infection by blocking conformational
change in gB or by preventing contact of fusion loops with the target membrane.
Interestingly, H126 neutralizes HSV entry to a similar extent in cells, regardless of
whether the cells support pH-dependent or pH-independent entry (49, 146) HSV-1 strain
ANG path has a highly fusogenic form of gB that is responsible for fusion-from-without
(FFWO) activity (149), (157). Two distinct mutations in gB are responsible for FFWO.
Notably, gB from ANG path has reduced reactivity with MAbs DL16 and H126 (146),
(48). Thus, the antigenic conformation of a mutant gB with enhanced fusion activity is
similar to the conformation of low pH-treated wild-type gB, supporting the notion that
acid pH triggers the fusion activity of gB.
As gB is the most-conserved herpesviral glycoprotein, similar low-pH activation of
gB from other herpesviruses may also occur. Cell monolayers transfected with gB or gD
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alone have been reported previously to undergo pH-dependent cell fusion (2, 26). Low
pH has little to no detectable effect on gD's antigenic structure or on its ability to bind to
receptors (125) (our unpublished data). The present data suggest that gB is the principle
glycoprotein affected by endosomal pH. However, acid effects on other glycoproteins
such as gH, which contains a putative fusion peptide (69), remain to be investigated
further.
Host cell triggers that can cause conformational changes in glycoproteins leading
to fusion include the low-pH milieu of the endosome, binding receptor, and cleavage by
endosomal proteases (185). HSV likely requires more than a single cellular trigger to
mediate membrane fusion and entry. HSV gD binding to one of its cognate receptors
causes a displacement of the C terminus of gD (99). This change in gD conformation is
thought to initiate the fusion process mediated by gB and gH-gL (8, 65, 169). In the case
of HSV entry into cells by acid-dependent endocytosis, we propose that the direct action
of endosomal pH on gB is required in addition to engagement of a gD receptor. While
we currently have no evidence for the involvement of pH-activated cellular proteases in
HSV entry (our unpublished data), other indispensable cellular triggers may be
necessary to complete the fusion process.
In addition to endosomal pH, one or more cell factors may serve the redundant
function of triggering conformational change in gB. In a similar vein, distinct cell
receptors serve a partly redundant receptor-binding role for gD. gB is required for pHneutral fusion of HSV with the plasma membrane of a subset of cell types, such as Vero
cells (27). The recently identified gB receptor PILR may trigger direct penetration of
HSV with the cell surface (6, 153). However, fusion probably cannot occur without a gD
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receptor and gD, even when PILR has a role (58, 153). All gB-specific neutralizing
antibodies tested have a similar inhibitory effect on HSV entry, regardless of whether
entry into the target cell type is dependent on intracellular low pH (50, 146). It is
tempting to speculate that in cells that support pH-independent entry, binding to a gBspecific receptor such as PILR may functionally substitute for endosomal pH and
induce a conformational change in gB that leads to pH-independent entry.
Unlike glycoproteins from viruses that mediate fusion exclusively at low pH, HSV
cell-cell fusion can occur at physiologic pH (176). Shown here, low pH enhances
membrane fusion mediated by gB, gD, gH and gL. Acid-activated gB alone causes cellcell fusion, indicating that the fusogenic potential of gB can be triggered by acid.
Interestingly, gB or gH independently appear to be sufficient to trigger fusion with the
outer nuclear membrane during HSV egress (59). However, the quartet of gB, gD, gH
and gL is necessary to mediate optimal fusion in the cell-cell fusion assay at neutral
(176) and low pHs, and likely during virus-cell fusion during entry.
Full-length gB from HSV-2 lacking only the transmembrane region (s-gB) was not
sufficiently hydrophobic to associate detectably with micelles of Triton X-114. Only upon
treatment with mildly acidic pH did s-gB associate with the detergent phase, suggesting
an increase in hydrophobic character. Interestingly, low-pH treatment of virions
increases their hydrophobic nature, as measured by binding to liposomes in the
presence of soluble receptor (183). gB is a likely candidate for mediating pH-triggered
association of virions with membrane. The similar effects of low pH on s-gB and on
virion gB suggest that the transmembrane-deleted gB used in this study may resemble
the prefusion form found in the virion envelope.
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The structure of a truncated form of HSV-1 gB (called gB730) is thought to be the
postfusion form (78, 103). Unlike s-gB, which becomes hydrophobic upon exposure to
low pH (Figure 5), gB730 is sufficiently hydrophobic at neutral pH to bind to liposomes
(73). The fusion loops are surface exposed in the gB730 structure and are responsible
for liposome binding. The absence of N-terminal or C-terminal residues from gB730 may
drive it irreversibly to the postfusion conformation, regardless of pH.
HSV gB undergoes a reversible change in structure in response to pH, similar to
the change in other class III fusion proteins, VSV-G (50) and baculovirus gp64 (194).
Thus, reversibility of conformational change may be a general feature of class III fusion
proteins. Interestingly, low-pH treatment of virions irreversibly inactivates viral entry
(125). This seeming paradox may be explained by irreversible pH-induced changes in
gB, gD, or gH-gL that have yet to be identified.
Our results suggest that low pH may cause a destabilization of the oligomeric
conformation of s-gB and virion gB. Similar disruption of soluble gB from HSV-1 was
reported previously (152). The observation that the functional region of gB that contains
the hydrophobic fusion loops is altered by mildly acidic pH suggests that low pH may
facilitate the proper gB-target membrane contact necessary for entry. In the case of
VSV, low pH causes a tighter association of G subunits, making them more stable (50)
In response to low pH, the bipartite fusion loops of each G monomer are thought to pack
as a trimer and contact the target membrane (142). In contrast, virion gB appears to
become a lower-order oligomer upon pH activation. This may be a difference in the
fusion mechanisms between these two class III fusion proteins. This distinction might
reflect the necessity of other HSV glycoproteins to complete the fusion process.
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IV. Structure-function analysis of HSV glycoproteins at low
pH.
Monoclonal antibodies detect low pH-induced conformational
changes in s-gB but not gB730
Conformational changes have been observed in the prefusion form of virion gBs
and a soluble form of gB that has only its transmembrane region (TM in Figure 4)
deleted (809 aa length, denoted s-gB) (Figures 10, 13, 14; Table 4; ). In contrast, an
ectodomain fragment of gB (700 aa length, denoted gB730) that has its membrane
proximal region, transmembrane region and cytoplasmic tail region deleted (Figure 4)
was reported to have essentially the same structure at both neutral and low pH (21, 78).
A later analysis confirmed that low pH did in fact effect functional region 1 of gB730, but
the effect was modest (163). gB730 may not be in the appropriate conformation to test
low-pH induced conformational changes. Both neutral and low pH structures still
maintain an overall postfusion (low pH) like structure (78, 141). It was therefore of
interest to directly compare low pH induced conformational changes in s-gB, which
undergoes conformational changes similar to virion gB, and gB730.
In order to compare conformational changes in the two forms of gB, we
measured reactivity to representative mouse monoclonal antibodies as in Figure 10. sgB and gB730 were exposed to pHs ranging from 7.4 to 4.8 and were immediately
blotted to nitrocellulose. 40 ng of each gB was added to each dot reaction. Polyclonal
antibody R69 reacted equally to similar amounts of s-gB or gB730. R69 also reacted
equally to gB that had been treated with the range of indicated pHs (Figure 16). Thus,
gB binding to nitrocellulose is unaffected by pH treatment. H126 that binds to an
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epitope in domain 1 of gB, displayed diminished detection to s-gB that had been treated
at lower pHs, as seen in Figure 10. In contrast, H126 detected gB730 to an equivalent
extent across the range of pHs, indicating that gB730 is not able to undergo the same
low pH induced conformational changes that s-gB can (Figure 16). SS106, which
detects conformational changes in domain V of gB, and DL16 which detects
conformational changes and is oligomer specific, were also used in this assay. SS106
detected low pH induced conformational changes in s-gB but not gB730 (Figure 16).
DL16 also detected conformation change in s-gB but only minor changes if any were
detected in gB730. SS10 epitope remained easily detected in all the conditions tested,
further indicating that gB730 does not undergo different conformational changes to s-gB
(Figure 16). Together, results indicate that gB730 most closely resembles a postfusion
form of gB that is less susceptible to pH relative to s-gB and the form of gB found in the
virion. It is possible that s-gB and gB730 undergo slightly different conformational
changes and that slight structural differences may account for this result.
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Figure 16. Antibody reactivity of purified recombinant gBs
40 ng of s-gB or gB730 were treated for 10 min at 37°C with medium buffered to the
indicated pHs and were blotted immediately to a nitrocellulose membrane. Blots were
probed at neutral pH with the indicated gB-specific antibodies, followed by horseradish
peroxidase-conjugated goat secondary antibody.
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Effect of pH on the hydrophobicity of gB730 and s-gB
Triton X114 partitioning was used to further probe how low pH affects the
hydrophobicity of HSV glycoproteins (as shown for s-gB in Figure 14) (24). As in Figure
14, there was increased detection of s-gB in the detergent phase at pH 5.1, suggesting
s-gB was triggered to become more hydrophobic at low pH. In contrast there was little
change in the partitioning of gB730 in response to pH 5.1 (Figure. 17). This suggests
that gB730 is not undergoing low pH induced changes that make it more hydrophobic.
Detection of gB730 in the detergent phase at neutral pH indicates that gB730 is
hydrophobic at neutral pH. This is consistent with the ability of gB730 to bind with
liposomes (73). In addition, the effect of pH on the detergent partitioning of gD was
investigated. Two soluble forms gD, gD-2t and gD(Δ290-299t) were studied. Detection
of gD in the aqueous phase and detergent phases was similar at pH 7.4 and 5.1. This
indicated that gD does not become hydrophobic in response to pH 5.1. Both forms of
gD appeared largely hydrophilic at both pHs. An alternative explanation for the increase
in s-gBs hydrophobicity at low pH may concern the protein expression system used.
Proteins expressed in mammalian cells (s-gB) may become hydrophobic at low-pH
whereas those expressed in insect cell do not (gB730). One explanation would be
differential glycosylation between expression systems. As gD-2t is also expressed in
mammalian cells this alternative explanation is may not be likely.
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Figure 17. Effect of low-pH treatment on the hydrophobicity of s-gB,
gB730, gD-2t and gD(Δ290-299t).
Proteins were added to 2% Triton X-114 that had been adjusted to the indicated pH.
Samples were incubated for 10 min at 37°C and were centrifuged at 300 x g for 3 min.
The aqueous supernatant phase and detergent phase were collected and diluted 20fold in PBS. Samples were subjected to immunoprecipitation (H1817 for gB, DL6 for gD)
followed by SDS-PAGE and immunoblotting (H1359 gB, DL6 for gD).
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Temperature dependence of conformational changes in gB
Like many biological processes, viral entry is slowed at temperatures below 37oC. The
triggering of conformational changes in fusion glycoproteins can be temperature
dependent (147, 166, 181, 184). To test whether conformational changes in HSV gB are
sensitive to temperature, HSV-1 KOS virions were subjected to a range of low pH at 4 ,
25, 37 or 50oC for 10 min and then analyzed by dot blot as described in Figure 10.
SS10 detected gB to an equivalent extent over the range of pHs and temperatures
tested (Figure 18). Thus, gB bound to nitrocellulose and was not degraded under
these conditions. A decease in H126 reactivity indicates low pH induced conformational
changes are occurring in Domain 1 of gB, as has been shown with virions incubated at
37oC. When virions were treated with the range of pHs at 4oC or 25oC, there was little to
no conformational change detected by H126 even at the lowest pH of 5.1.
At 50oC there was diminished detection at pHs higher that those seen at 37oC. This
suggests that low pH-induced conformational changes in gB may be enhanced by
treatment at 50oC. Together these results suggest that warm temperatures enhance
conformational changes and colder temperatures inhibit them. Although not directly
compared hear, virus entry is inhibited by temperature. This is consistent with a
biologically relevant role for the conformational changes.
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Figure 18. Antibody reactivity of HSV KOS virion gB over a range of
pH and temperature
Extracellular HSV-1 KOS virions (105 PFU) were treated for 10 min at the indicated
temperatures with medium buffered to the indicated pHs. Samples were then cooled to
4oC and blotted immediately to a nitrocellulose membrane. Blots were probed at neutral
pH with the indicated gB-specific antibodies, followed by horseradish peroxidaseconjugated goat secondary antibody.
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Effect of low pH on the antigenic conformation of HSV gD and its
receptor binding function
Analysis of gB, gD and gH-gL revealed that HSV gB may be the principal
glycoprotein affected by low pH. Further analysis of low pH induced conformational
changes in virion gD was performed with monoclonal antibodies. HSV virions were
treated with a range of pHs from 7.4 to 5.2 and were probed with a panel of anti-gD
monoclonal antibodies that bind to distinct regions across gD (Table 3) (37, 55, 85, 115,
121). Monoclonal antibodies to the C-terminal region (DL6), the Ig-like core (DL11, DL2)
and the N-terminus (1103) reacted to virion gD to an equivalent extent regardless of the
pH of treatment. R7 a polyclonal antibody to gD was used as a control and detected gD
to an equivalent extent under all the conditions tested (Figure 19). For comparison, the
same virion preparation was probed with anti-gB monoclonal antibodies H126 and
H1817, indicating that low pH conformational changes in HSV glycoproteins are
detectable under these conditions. It cannot be ruled out that gD is undergoing low pH
induced changes that we did not detect.
Having shown previously that low pH impairs HSV entry function, we determined
whether low pH affects the ability of gD to bind to the gD receptors(127). The ability of
acid-treated, soluble gD to bind to HVEMt or nectin-1t was evaluated by a binding
ELISA (98, 182). Soluble gD that was treated with pH 4.7 bound to immobilised HVEMt
in a dose-dependent manner similar to that of untreated gD(Δ290-299t) (Figure 20A).
Control, heat-treated gD(Δ290-299t), however, had severely diminished binding activity
(Figure 20A). Acid-treated and untreated gD(Δ290-299t) also bound comparably to
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immobilised nectin-1t (Figure 20C). Taken together the results indicate that low pH pretreatment had no effect on the interaction of gD with its receptors, supporting the notion
that the conformation of gD responsible for receptor binding is not affected by pH. Also,
pH triggered inactivation of HSV occurs at a required, post-gD binding step in entry.
.
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Figure 19. Antibody reactivity of low pH-treated virions
Extracellular HSV-1 KOS virions (105 PFU) were treated for 10 min at 37°C with
medium buffered to the indicated pHs and were blotted immediately to a nitrocellulose
membrane. Blots were probed at neutral pH with the indicated gB or gD-specific
antibodies, followed by horseradish peroxidase-conjugated goat secondary antibody.
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Figure 20. Effect of low pH pre-treatment on binding to HSV entry
receptors
A) and (B) Low pH-treated soluble gD binds to receptors. Microtitre plates
coated with (A) HVEMt or (B) nectin-1t were incubated with increasing concentrations of
gD(Δ290-299t) that had been heated to 80˚C, treated at pH 4.7, or left untreated. Bound
gD was detected with MAb DL6 followed by peroxidase-conjugated Protein A and
substrate. Absorbance was read at 410 nm. Each value represents the average of
duplicate wells.

100

101

Effect of pH on the intrinsic fluorescence of purified HSV
glycoproteins
The intrinsic fluorescence emission spectra of purified glycoproteins s-gB,
gB730, gD-2t , gD(Δ290-299t), gC and chicken ovalbumin were recorded at pH 5.1 and
7.3 (Figure 21A). Intrinsic fluorescence is a common way to study conformational
changes in proteins, including viral entry glycoproteins (Influenza-HA, VSV-G) (29, 96,
139) Tryptophans are the dominantly fluorescent amino acid of proteins and are excited
with photons of 280 nm wavelength. The degree of excitation depends on the
environment of the tryptophan. Hence, when tryptophans return to ground electronic
state, a photon is released at a wavelength determined by its environment (101). If a
proteins peak emission wavelength shifts from a starting point towards the red end of
the spectrum, this indicates exposure of tryptophans to the solvent. A blue shift in the
emission spectrum indicates internalization of tryptophans within the protein (101). Both
s-gB and gB730 have 7 tryptophans in highly conserved regions of gB (Figure 22), this
makes direct comparison by this approach more powerful.
At the neutral pH of 7.3 s-gB had a peak emission at 330.4 nm. Upon treatment
at the pH of 5.1, the peak fluorescence of s-gB shifted 2.2 nm towards the red spectrum
(Figure 21). This suggests that tryptophan residues are exposed as s-gB undergoes low
pH induced conformational changes. Interestingly when gB730 was treated at low pH, a
1 nm blue shift in gB730 emission spectra occurred. This may indicate that gB730
undergoes a small conformational change that is different to s-gB. This is consistent
with the antigenic and hydrophobicity analysis (Figures 16 and 17), which indicate that
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the conformational change in gB730 is not as great as that in s-gB. We observed in
Figure 12 that low pH induced conformational changes in gB are reversible upon
neutralization. Reversibility of conformational change is a characteristic of class III
fusion glycoproteins. The reversibility of gB conformation change was tested in parallel
with the low pH spectra shift study (Figure 21. light gray solid line). Upon neutralization
peak fluorescence of low pH, both s-gB and gB730 shifted back to within 0.2 nm of their
fluorescence at neutral pH. This is further evidence that low pH induced conformational
changes in HSV gB are reversible. This is antibody-independent, biophysical evidence
that herpes virus gB undergoes reversible, low pH-induced conformational changes.
The fluorescence emission spectra of ovalbumin, gC, gD-2t and gD(Δ290-299t) were
very similar at a pH of 7.3 or 5.1 (Figure 21). This indicates that under these conditions
(see materials and methods) these proteins do not undergo detectable low pH induced
conformational changes. At high (24 ng/µl) protein concentration the emission spectrum
of gD-2t underwent a 4 nm blue shift. The shift in gD-2t was absent at lower
concentration. Thus, the shift is likely attributable to concentration dependent protein
aggregation and not biologically relevant conformational change. The absence of
conformational changes in these other proteins further indicates that changes in s-gB
are specific.
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Figure 21. Low pH induced conformational change as determined by
intrinsic fluorescence

A) The spectral profiles of the indicated proteins were determined at neutral and low pH.
For gB neutralized samples are also shown.
Excitation was performed at 280 nm. Emission was recorded over 310-400 nm. The
peak fluorescence in percent is shown. Shifts in peak fluorescence indicate net
exposure (nm increase) or internalization (lower nm) of tryptophans as conformational
change occurs.

B) Comparison of size and nature of conformation change. Peak fluorescence at neutral
pH was normalized to 0. Shape positions indicate how many nm in wavelength and in
which direction each spectrum shifted from 0 upon encountering low pH.
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Figure 22. Clustal W alignment of gBs used in this study.
A clustal W multiple sequence alignment of virion and soluble gBs. Alignment
was performed using EMBLs clustal W data base. A full alignment was performed using
the default settings. Tryptophans are highlighted with W. The sequences aligned are
labeled as follows.
333 = HSV-2 strain 333
S = s-gB (cloned from HSV-2 strain 333)
KOS = HSV-1 KOS
730 = gB730 (from HSV-1 KOS)
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Table 5. Statistics of gB clustal W alignment.
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Fusion loop mutants of gB
To probe the relationship between the conformational changes and the fusion
function of gB, we determined the effect of mildly acidic pH on gB bearing mutations in
its fusion loops (Figure 23A) (73, 74, 170, 192). Substituting polar residues for
hydrophobic residues in the fusion loops of gB diminished fusion activity in a cell-cell
fusion assay (74). Surface expression of gB with fusion loop mutations was shown to be
similar to KOS gB expressed from the same plasmid (74). It is hypothesized that
hydrophobic residues in the bipartite fusion loops of gB are required for the insertion of
gBs fusion domain into the host cell membrane (Figure 24) (74, 170). If fusion loop
mutants are defective for insertion into the host membrane they will not cause fusion but
may still undergo low pH induced conformational changes. Alternatively, mutations in
the fusion loops may result in gB that undergoes either altered conformational changes
or, no change at all. Because high titres of these mutant viruses are difficult to obtain,
assays for the conformational change were performed on lysates of cells infected with
mutant viruses. Viruses were initially made from the BAC-gBgalK/gH background. Cellassociated virus samples have either no gB (gBgalK/gH-), KOS gB (w.t.gB/gH-), gB with
the fusion loop 1 mutation Y179K, or a fusion loop 2 mutation A261D (Figure 24) (192).
All viruses lack gH but were propagated in gH-complementing F6 cells. A brief
description of the construction of the fusion loop mutants is detailed in the Materials and
Methods.
Amounts of cell-associated virus that reacted equally to MAbs prior to pH
treatment were exposed to pHs ranging from 7.4 to 4.8. They were then immediately
blotted to nitrocellulose membranes. Antibody binding was then assessed at pH 7.4.
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Representative monoclonal antibodies to specific regions of gB were used to analyze
low pH induced conformational changes as in Figure 10. Importantly, MAb H126
(domain I), SS106 (domain V), SS10 (domain III) and DL16 (oligomer specific) detected
antigenic changes in cell-associated KOS gB to an extent equivalent to that seen in
HSV KOS virions (Figure 24A). pH induced changes in domains I, V and oligomeric
changes occur at a similar threshold (~pH 6) to virion gB. This indicates that cellular gB
is capable of undergoing the same low pH induced conformational changes seen in
virions. Analysis of gB with the fusion loop 1 mutation, fusion loop 2 mutation and gB
rescued virus was performed. This revealed that all gBs are able to undergo specific
antigenic changes in domain I (H126), domain V (SS106) and also oligomeric changes
(DL16). Low pH induced changes in these regions are equivalent in nature to those
seen in cell associated HSV-1 KOS gB, virion gB, and soluble gB. This suggests that
fusion loop mutants of gB are defective for fusion for reasons other than impaired or
altered conformational changes. The detergent stability of the fusion loop mutants was
analysed with the native gel assay as in Figure 11C. Once again at around a pH of 6 the
upper oligomeric band of each gB became unstable (Figure 24B). This indicated that all
of the cell lysate gBs underwent similar changes in oligomeric stability as seen for virion
gB (Figure 23). Cell-associated gB, and fusion loop mutant gBs appear to undergo low
pH induced oligomeric changes.
The reversibility of conformational changes in cell-associated WT gB, gB A261D
and gB Y179K was analysed. It was possible that a defect in reversibility was
responsible for diminished fusion function of mutant gB. A MAb dot blot assay for
reversibility was used as in Figure 12. In each of the gBs tested domain epitopes to
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H126, SS106, and Dl16 had diminished detection at pH 5.3 (Figure 25A). Detection was
at least partially restored by neutralizing pH to 7.4 prior to binding. To further the
analysis a native gel SDS assay to test reversibility of changes of an oligomeric nature
was used as in Figure 11C. At the pH of 5.3 the upper oligomeric band of gB is no
longer detected (Figure 25B). Neutralizing the sample prior to the addition of SDS made
the upper band detectable again indicating that pH-induced changes of an oligomeric
nature are reversible in all samples.
The dot blot and SDS assay both reveal that cell associated WT gB and gB with
mutations in either fusion loop, undergo low pH induced conformational changes that
are reversible in nature. These are similar to those seen in virion gB (Figures 11C and
12).
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Figure 23. Mutations in the fusion loops of gB
HSV gB hydrophobic ridge is surrounded by charged residues on the surface of the
molecule. A ribbon diagram of the HSV protomer (A) and molecular surface
representation of the trimer (B) are shown. In each, one protomer is colored by
secondary structure succession, using blue (domain I), green (domain II), yellow
(domain III), orange (domain IV), and red (domain V). The box in panel A shows the
primary amino acid sequences of the fusion loops. The box in panel B shows the base
of the gB trimer, rotated 90°. For the boxes in both panels A and B, highlighted
hydrophobic residues are colored in blue and charged residues are shown in red. All
structural figures were generated, in part, using PyMOL Molecular Graphics System
software.
(Reproduced with permission from the publisher (74)
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Figure 24. Low pH induced changes in cell-associated wild type gB
and fusion loop mutant gB

A) Dot blot analysis
The indicated infected Vero or derived F6 cell lysates were diluted in buffered media to
achieve final pHs ranging from 7.4 to 5.2. Samples were incubated at 37 ˚C for 5 min.
and blotted directly to nitrocellulose. Membranes were blocked and incubated at neutral
pH with anti-gB monoclonal antibodies H126 (Domain I), SS10 (Domain III), SS106
(Domain V), DL16 (trimer-specific). After incubation with horseradish peroxidaseconjugated goat-anti-mouse antibody, enhanced chemiluminescent substrate (Pierce)
was added, and blots were exposed to X-ray film (Kodak).

B) Assay for sensitivity of oligomeric gB to detergent
The indicated infected cell lysates were treated with medium adjusted to pHs ranging
from 7.4 to 5.2 as described for panel A. Lysates were adjusted to 1% SDS and were
then added to PAGE sample buffer containing 0.2% SDS and no reducing agent
(“native” conditions). Samples were not heated and were resolved by PAGE. After
transfer to nitrocellulose, membranes were blocked and incubated with rabbit polyclonal
antibody specific for gB. After incubation with horseradish peroxidase-conjugated goatanti-rabbit antibody, enhanced chemiluminescent substrate (Pierce) was added and
membranes were exposed to X-ray film (Kodak).
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Figure 25. Reversibility of conformational changes for fusion loop
mutants
A) Reversibility of pH-induced conformational changes in gB from infected cell lysates.
Cell-associated gB preparations were treated with medium buffered to pH 7.2 or 5.5.
For the indicated samples, pH was neutralized back to 7.2 for 10 min at 37°C and
blotted immediately to nitrocellulose membranes. Membranes were probed at neutral
pH with the indicated antibodies, followed by horseradish peroxidase-conjugated
secondary antibody.

B) Cell-associated gB preparations were treated with the indicated pH, treated with 1%
SDS, and then analyzed by PAGE and immunoblotting for detection of gB.
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Modification of virion histidines by DEPC treatment preferentially
inhibits pH-dependent endocytic entry
Histidine protonation is believed to be important for the low pH activation of
several viral fusion glycoproteins (30, 95, 120, 164). Histidine is the only amino acid that
has a pKa in the physiological pH range found within the lysosome terminal endocytic
pathway (120). The pKa of histidine is 6.1 and conformational changes in gB occur at a
pH of pH 5.9. Protonation of histidines may thusly trigger membrane-fusion-inducing
conformational changes within gB, as HSV encounters the low pH of endosomes.
Modification of the N-omega-2 nitrogen of the imidazole ring in histyl residues in
proteins can be accomplished by reacting with diethylpyrocarbonate to produce Ncarbethoxyhistidyl derivatives. DEPC has been used to inhibit the entry of several low
pH-dependent viruses (164, 165). In order to study histidine modification, HSV-1 KOS
was pelleted by ultra-centrifugation and virions were resuspended in PBS. Concentrated
virus was treated with DEPC and diluted in an excess of media. Infectivity was then
analyzed in the indicated cell types via β-galactosidase reporter assay (CHO-derived
cells) or plaque assay (Vero and HaCaT cells) (Figure 26). At high concentration of
DEPC treatment, infection by DEPC treated virus was undetectable suggesting that
protonation of histidines is important for HSV entry. As shown in Figure 26, low
concentration DEPC treatment of virus preferentially inhibited HSV entry into cells that
support low pH endocytic entry of HSV (CHO-nectin-1 and HaCaT). Entry into cells that
support pH-independent entry (Vero and C10) was inhibited to a lesser extent. This
suggests that histidine residues may be more important in the low pH entry pathway of
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HSV in which endosomes serve as a potential source of protonation.
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Figure 26. Analysis of infectivity of DEPC treated virions

Virions of HSV-1 KOS were concentrated and resuspended in PBS. 50 µg of virus was
treated with the DEPC concentration indicated for 10 min. Infectivity was then analyzed
in the indicated cell types via β-galactosidase reporter assay (CHO-nectin-1 or C10
derived cells) or plaque assay (Vero or HaCaT).
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Discussion
In nature class III fusion glycoproteins exist in a metastable equilibrium between
conformations (141, 143). It is demonstrated that gB730 was constructed in such a way
that restricts conformation change. Limiting gB conformational changes may have
been beneficial in the crystallization of gB as crystals would have been more
organized(78). In the future, experimental designs should be mindful of the restrictions
imposed by using gB730. Several published experiments with gB730 now also have
alternative explanations than those documented due to this finding (8, 9, 78, 163). Most
importantly to my work, the recent publication of a low pH form of gB730 does not likely
reveal the pre to postfusion transition of gB (163). gB730 should not be expected to
undergo the full range of conformational changes observed during fusion because it
represents a postfusion (low-pH) form that has already been activated.
Of note, the s-gBs and gB730 are different; s-gB has only the TM region missing
while gB -730 is missing around 100 amino acids more then s-gB. Also, s-gB is from
HSV-2 strain 333 and is produced in mammalian cells while gB730 is from HSV-1 strain
KOS and is produced in insect cells (see Materials and Methods). The gBs are from
different origins and there maybe potential differences in triggering mechanisms for the
two glycoproteins. However, low pH induced conformational changes seen in gB from
KOS virions match those of s-gB. Therefore, if biologically relevant low pH induced
conformational changes were occurring in gB730, they would likely be similar to those
detected in KOS virion gB, and should have been detected. Several reasons why gB730
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is unable to change conformation include, differences in glycosylation and processing,
or different deleted regions that result in different conformations.
If that gB730 is in a single low-pH postfusion conformation, domain 1 and 5
reactivity to antibody could be expected to be diminished prior to pH treatment. It could
be speculated that epitopes were not diminished in gB730 because the pre- fusion
conformation of s-gB and the structure of gB730 are similar. Alternatively, we may be
detecting an extended intermediate conformation of s-gB. Another cellular or viral cue
may be needed, before that gB can complete conformational change and adopt a
structure like that of gB730. Alternatively, gB730 may be aberrantly folded with these
epitopes exposed. If conformational changes in gB are reversible, and gB730 was
functional then crystallizing gB at neutral pH should have revealed the prefusion form of
gB (78, 163). As conformational changes did not occur, regions of gB730 may be folded
in a way that does not occur in the virus.
Interestingly, gB730 was recently shown to adopt head-to-head structures in
which functional region 1 of two adjacent timers gB730 associate in response to low pH
(163). With regards to the intrinsic tryptophan fluorescence experiments, such an
arrangement may bury the tryptophan in fusion loop 1. This would account for a shift in
wavelength without significant conformational changes occurring (101). Both gBs have
7 tryptophans in regions highly conserved between the two gBs, so it is unlikely
differences in conformational changes are due to differences in the relative positions of
tryptophan between gBs (see clustal alignment Figure 22; Table 5). A potential
explanation for exposure of the tryptophans of s-gB is that protomers are becoming
unstable and disassociating at low pH. Disassociation may not be a plausible
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explanation as we show in Figure 13 that ionic detergent is needed to break
hydrophobic interactions at s-gBs protomer interface. In addition, disassociation would
likely result in the increased exposure of epitopes at low-pH. Together the intrinsic
fluorescence data are consistent with low pH induced conformational changes in s-gB
that are larger than those seen in gB730, especially given that trimers of gB730 may be
associating (for comparison see Figure 21 B). Association of gB730 trimers at low pH
(and not conformational change) would also explain why we do not see conformational
changes in gB730 in our other data. Many of the analyses suggest that conformational
changes in s-gB match those seen in virions during endocytic entry.
In general, numerous low-pH structures of several class III glycoproteins have been
labeled “postfusion” (13, 78, 90). For class I and II fusion glycoproteins postfusion and
low-pH conformations are the same, as conformational changes are final and nonreversible (185). Due to the reversible nature of the conformational changes in class III
glycoproteins, it may be more accurate to say that the low pH structures are
glycoproteins in a fusion active conformation. Following fusion (postfusion), the
glycoproteins would encounter the neutral pH of the cytoplasm and undergo reversal of
conformational change so the true pre- and postfusion conformations may be identical.
The temperature-dependence of conformational change in gB is characteristically
similar to a number of other glycoproteins (147, 166, 181, 184). The inhibition of
conformational change maybe due to a lower free energy of gB-ligand interaction, or for
gB conformational change post ligand-binding. In addition, decreased membrane fluidity
at low temperature may have a role (166, 184), although soluble gB in the absence of
membrane can undergo conformational changes. Interestingly, HSV inactivation with
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low pH is also inhibited by low temperature (125). This correlation opens up the
possibility that irreversible conformational changes not yet detected in gB or other
glycoproteins may be responsible for viral inactivation by low pH.
gD does not undergo detectable low pH induced conformational changes and is
unaltered in receptor binding after treatment with low-pH. It is not clear at which point
during endocytosis that receptor binding occurs (124, 125, 127). gD receptor interaction
at low pH may still be affected by undetected changes in gD or low pH induced changes
in the receptor itself. These data indicate that gD is not triggered for fusion by low pH.
Future work will study if that gD bound to receptor undergoes conformational changes in
response to low pH. We cannot rule out the possibility that gD is activated by low pH
after receptor binding to perform another function during entry.
Until identification of conformational changes in gB it was unclear how the energy
needed to drive two membranes together may be provided. It had been shown that
gB730 could associate with liposomes by its fusion loops and a similar role in
membrane fusion was implicated (74). It is suggested here that combination of
conformational change and functional hydrophobic fusion loops are needed for fusion.
Conformational changes in domains 1 and 5 of gB alone are not sufficient for fusion.
Recent experiments show that gB730 when added in trans cannot cause membrane
fusion in a cell-cell fusion assay (with gD and gH-gL) (9). This suggests that association
of gB fusion loops with membranes alone is also not sufficient to cause membrane
fusion. This is further evidence that the combination of conformational change in gB and
insertion of gB fusion loops into host membrane are needed. I favor the explanation that
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hydrophobic residues are needed for insertion of gB fusion loops into the host cell
membrane enabling conformational changes in gB to drive the membranes together.
DEPC modification of histidines in HSV KOS, inhibits low pH dependent entry
more that pH independent entry. This is consistent with histidines being important in the
pH sensing mechanism of low pH induced membrane fusion (30, 95, 120, 164). In the
case of pH independent entry, histidine modification of gB may cause steric hindrance
thereby affecting fusion and entry. The importance of histidine modification may be
masked by effects that DEPC is having either in gB, or other components of the virus.
At higher concentrations DEPC likely modifies histidines in other motifs of several
molecules that are essential to both entry pathways of HSV. Further work will study if
that gB conformational change is inhibited at lower DEPC concentrations. As DEPC
inhibition of endocytic entry over plasma membrane entry may have been expected to
be larger, other amino acids may play a role in the pH sensing mechanism of gB
activation. Amino acids such as arganine can have their pKa altered to physiological
pH due to interactions with neighboring residues.
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V. Analysis of gB structure during synthesis and maturation.

The antigenic conformation of virion gB is distinct from cell
expressed gB
Several glycoproteins undergo steps in which their properties change throughout
synthesis, processing and release from the cell (102, 119, 185). To investigate the
possibility that gB may achieve distinct conformations during processing,
immunoprecipitation studies were performed to compare virion gB to gB from the
infected cell (Figure. 27). Of the panel of antibodies tested antigenic differences
between cell and virion gB were seen for H126 and SS10. H126 and SS10 detected
more gB in the virion than in the cell relative to H1817. This indicates that gB in the
virion is conformationally distinct from cellular gB. Since we IP at neutral pH, and pHinduced conformational changes are reversible, it is not likely that we are detecting
conformational changes due to low pH. In addition, other epitopes known to be sensitive
to pH do not behave the same way as the H126 epitope in this experiment, and SS10
was shown to be unaffected by pH treatments and appears changed in this experiment.
These data are consistent with virion gB having a conformation that is distinct from
cellular gB.
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Figure 27. Antigenic conformation of virion gB vs. gB in infected cells
HSV-1 KOS gB from virions or from cell lysates was immunoprecipitated (Pro A
agarose) with specific anti-gB antibodies. Immunoprecipitation conditions were identical
between samples. Cell lysates were prepared by infecting Vero cells with HSV-1 KOS
(MOI 5) for 6 hrs. Cells were than detergent lysed (CHAPS). MAbs H1817, SS10 and
H126 are shown. Samples were analyzed by SDS-PAGE and Western blotting.

128

129

Alteration of intracellular pH affects antigenic conformation of newly
synthesized gB
It is believed that class III fusion glycoproteins undergo reversible conformational
changes to allow them to remain fusogenic as they encounter the low-pH of the transGolgi network (77, 141-144). To test whether low pH is causing conformational change
in newly synthesized gB, intracellular pH was elevated by treatment with the
lysosomotropic agent Bafilomycin A1 (BFLA). LCSM revealed that treatment of cells
with BFLA increased detection of gB with MAb H126 but not PAb R69 (Figure 28 top).
ImageJ quantification of micrographs revealed that BFLA detection in panel D is 3040% greater then C. This is consistent with gB undergoing specific conformational
changes as it traverses a low pH compartment.

Cellular gB is found in antigenically distinct populations
It is known that gB performs several functions at different locations in the cell (17,
20, 153, 156, 176, 192) and, I have several lines of evidence to suggest that cellular gB
can undergo conformational change (Figures 10, 11, 14 and 21). We investigated the
possibility that gB adopts different antigenically distinct conformations in different
locations within the cell. Infected Vero cells at 6.5 hrs post infection were analyzed by
LSCM (Figure 28 lower panel). HSV gB-specific polyclonal antibody (PAb) R69 reacted
with total cellular gB at the nuclear membrane, ER/Golgi compartments, punctate
compartments throughout the cell and the plasma membrane (Figure 28A). In contrast,
MAb DL21 reacted preferentially with punctate compartments reminiscent of acidic
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endosomes/lysosome. SS118 preferentially recognized gB present at the nuclear
membrane and plasma membrane, these are both known sites of membrane fusion and
suggest that a common event may be responsible for the distinct antigenic
conformation. Several MAbs such as H126 and SS55 preferentially detect gB in perinuclear compartments such as the Golgi. Together, these data suggest that there may
be four or more different populations of gB found in the cell and virus.
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Figure 28. Detecting pH-induced conformation change in newly
synthesized gB

A-D) Top panel:
Vero cells were infected with HSV-1 KOS (MOI of 5). At 6.5 hr p.i. cells were fixed with
3% paraformaldehyde and permeabilized with 0.2% Triton X-100. B and D were treated
from 1 hr PI with Bafilomycin A1. A and C were mock treated. HSV gB was detected in
A and B with PAb-R69 and in C and D with MAb H126. Visualization was by LSCM at
63X magnification. Arrows indicate gB at the plasma membrane (PM), nuclear
membrane (NM), Golgi-like perinuclear location (PN) or at punctate vesicular
compartments (P).

Bottom panel:
Vero cells were infected with HSV-1 KOS (MOI of 5). At 6.5 hr p.i. cells were fixed with
3% paraformaldehyde and permeabilized with 0.2% Triton X-100. HSV gB was detected
with indicated antibodies . Visualization was by LSCM at 63X magnification.
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Pulse chase analysis of HSV gB reveals co-translational folding and
trimerization of gB
To monitor the folding of gB as it is synthesized on the ribosome, gB epitopes
were monitored over time using pulse-chase analysis (Figure 29) (102). A short pulselabel of 100s was used to define a population of gB. Assuming an elongation rate of
around 3 amino acids per second, based on the average rate of translation in
eukaryotes, a 100 second pulse would label less than half of the 904 amino acid gB (33,
123). Each of the 8 distinct epitopes tested were weakly detected directly following a
100 second pulse, indicating that gB begins folding prior to release from the ribosome
and translocon. In addition, the oligomer-specific MAb DL16 also detected gB directly
following the pulse. This indicates that gB is oligomerizing while still attached to the
ribosome. The correct folding of gB must begin rapidly if it is recognized by a
conformation-dependent oligomer-specific antibody. There was no reproducible
difference in detection of conformation-dependent or independent epitopes. Following
pulse, gB was chased over time. All epitopes appear to peak at 1 hour chase. This
suggests that folding is continuing post-translationally. There are several epitopes that
appear to have diminished detection at 2 hours chase. This suggests that following
peak folding, additional events concerning the antigenic conformation of gB are
occurring.
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Figure 29. Pulse chase analysis of gB folding
Vero cells were infected with HSV-1 KOS at an MOI of 5. At 6 hr p.i. cells were pulse
labeled with (400 µCi) 35S- labeled cysteine and methionine (MP biosciences) for 100 s.
Wells were processed without chase (0) or chased for the indicated time in excess cold
cysteine and methionine plus cycloheximide. Cells were lysed at 4oC with CHAPS in the
presence of N-Ethylmaleimide. Samples were immunoprecipitated (IP) for 2 hr using
Pro A agarose beads and specific anti-gB antibodies. Samples were boiled in nonreducing Laemmli buffer and analyzed with 6% SDS-PAGE and autoradiography.
Quantitation was performed using the Measure function of NIH ImageJ 1.38X.
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Discussion
Figure 15 demonstrates that gB undergoes conformational changes during viral
entry. Here, it is demonstrated that gB can be found in several antigenic conformations
in different places within the cell and virion (Figure 27 and 28). Firstly, it was established
that total cell associated gB is antigenically distinct to virion gB. There are several
interpretations of this; 1.) gB may have a binding partner that occludes epitopes in the
cell, the binding partner may release upon virion maturation exposing the epitopes. 2.)
These epitopes may not develop until gB is close to being incorporated into the virion,
and may signify a maturational step for the glycoprotein. 3.) gB may undergo
conformational changes within the cell that depletes these epitopes. 4.) gB with these
epitopes may be preferentially incorporated into virions or degraded within the cell.
Class I and II glycoproteins undergo proteolytic maturation steps late in
processing (1, 52, 53, 185). Maturation steps prevent premature triggering and fusion of
viral fusion glycoproteins (185). This maybe the first evidence of a maturation step in
class III fusion glycoprotein synthesis.
Interestingly, MAb SS10 maps to a region close to the putative receptor-binding
region of gB (6, 58, 153). If these antigenic differences are not due to a fusion
maturation step, then HSV may have evolved a way to shield the receptor-binding
region of gB. This would prevent premature binding of receptor. Premature receptor
binding represents a problem for numerous viruses and there are several known
examples of how viruses circumvent this problem. The most attractive example to note
is that of influenza neuraminidase. Neuraminidase cleaves sialic acids on glycans to
which influenza is bound (reviewed in (66). The glycans would otherwise bind virions at
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the cell surface indefinitely. The structurally designed anti influenza drugs Relenza and
Tamiflu are both neuraminidase inhibitors. Further work may reveal this antigenic
change is indicating an attractive drug target for HSV.
Several antigenically distinct populations of gB were seen within the cell via
confocal microscopy. How these relate to function is not clear. Colocalization with
cellular markers will help characterize compartments that contain gB. However, it must
be remembered that cellular markers are rearranged in herpes virus infected cells (42,
76). From the corresponding light images (not shown) it is indicated that SS118
preferentially detects gB at the plasma membrane and the nuclear membrane. These
are both sites of membrane fusion (25, 125, 192). Antigenically distinct gB was also
seen in punctate compartments within the cell. It is unclear what compartments these
are. They may represent secretory vesicles on the way to the cell surface, endosomes,
recycling endosomes, lysosomes or a mixture of several of these. gB is known to
recycle from the plasma membrane to recycling endosomes, and a mutant of gB is
known to be retained at the cell surface (17, 18). It maybe of interest to examine
structure-function correlations in recycling defective gB. Another antigenically distinct
population of gB stains in a pattern reminiscent of the ER Golgi. This population may
have epitopes that are detected more strongly during processing, or that rapidly leave
the cell in virions. In all of these populations differential detection may be due to
changes in conformation, or gB may alternatively release or bind to a binding partner
that occludes the epitope at different sites within the cell. Pulse chase analysis of gB
folding did not yield any relatable findings regarding the appearance or disappearance
of these epitopes. Pulse labeling indicated that these epitopes of gB appear (and peak)
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at around the same time, whether antigenic differences are the cause or effect of gBs
arrival in these distinct populations also remains to be seen.
Pulse chase also revealed that a small population of gB trimerized on the
ribosome. Whilst co-translational protein folding is now thought to be common for many
epitopes of large proteins (22, 57, 63, 75, 86, 93, 123, 136, 150), detection of
cotranslational oligomerization has only been demonstrated for a small number of
proteins (38, 70). Notably examples of these include viral glycoproteins (70). This
suggests a parologously evolved functional reason for viral glycoprotein cotranslational
oligomerization. Perhaps protomers are functioning to chaperone folding of their
adjacent counterparts without being released as true chaperones are. This may obviate
the need for the virus to encode separate chaperone proteins while aiding the folding of
metastable trimers.
Class I and II glycoproteins avoid premature irreversible activation by having a
maturation step that occurs after they encounter potential triggers. Here we show that
gB is undergoing conformational changes in the secretory apparatus, acting like other
Class III glycoproteins. The reversible nature of these changes means that gB is able to
refold into a triggerable conformation post-neutralization. Pulse chase was used in an
attempt to verify these data (not shown) but only a modest increase of the H126 epitope
was seen in the presence of BFLA. We believe that the reversible nature of the
conformational change meant that in the neutral pH of immunoprecipitation,
conformational changes were reversed. In contrast, fixation of the epitopes prior to
antibody binding allowed detection of conformational changes with LSCM. These data
provide intriguing insights into the genesis and function of gB within the cell and virus.
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Taken together, a possible order of events would be; gB cotranslationally folding and
oligomerizing, then undergoing reversible changes as it traverses the secretory
apparatus. gB may migrate to several sites in the cell where it has different binding
partners or different conformations. One population of gB then undergoes a
maturational step at a point close to incorporation into the virion. Infectious virions are
released from the cell and the viral lifecycle continues. Figure 30 summarizes the
antigenic data presented here for gB during virus entry and egress.

140

Figure 30. The antigenic conformation of gB throughout the HSV
lifecycle
This summarizes the conformational changes that were identified throughout sections
III, IV and V. Details regarding non gB related events that may be inferred form the
figure have been previously described in Figure 3.
A) A ribbon cartoon of a monomer of gB. Domains are indicated by roman
numerals and color-coding. Antibody binding regions are indicated as previously
detailed in Table 2.
B) During the endocytic entry pathway of HSV, incoming virions encounter the
low pH of an acidic compartment consistent with endosomal pH. The low pH then
triggers conformational changes in domains I and IV of gB. pH induces changes are
detected by epitopes prefixed by a star. DL16, which is oligomer specific, indicates
oligomeric changes in gB are occurring in response to pH.
During viral replication, as viral egress is occurring, gB is preferentially detected
in certain cellular locations. A pound prefixing an antibodies name indicates preferential
detection. In addition, the H126 epitope on gB was shown to be sensitive to the low pH
encountered during gB synthesis (pH sensitivity again indicated by the pound).

Black arrows indicate virion movement (entry and egress).
Blue arrows indicate capsid movement (egress).
Red arrows indicate glycoprotein movement in synthesis and maturation.
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Green arrows point to the locations where gB epitopes are either pH sensitive or are
preferentially detected.
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Future directions
Several avenues of further study have been indicated throughout. Further work
generating and analyzing mutations of gB is desirable. We have shown that fusion loop
mutants can undergo conformational changes but not accomplish fusion. Further
mutations are needed to delineate regions in gB that are necessary for conformational
change. It would have to be predicted that mutants that are defective for conformational
change, would be defective for fusion. It would also be interesting to see whether that
gBs from other herpes viruses could undergo conformational changes using similar
approaches. In comparing and contrasting the mechanisms that build up to membrane
fusion, we may identify novel steps.
An antigenic analysis to monitor any low pH induced conformational changes in
gH-gL is absent from this work and is also a future direction. In addition, although the
low pH induced cell-cell fusion is reproducible it is still being perfected.
The cell-cell fusion assay (with and/or without pH) could also be extended to
include many other HSV glycoproteins that have currently not been evaluated in their
fusion function. There may be entire regulatory pathways that lead to fusion that are
circumvented by leaving out so many membrane proteins. In addition, CMV has
proteins that direct the entry pathway taken into certain cell types. There may well yet
be an analogous protein or complex of proteins in HSV. A comprehensive analysis of
HSV deletion mutant viruses may reveal proteins that direct the entry pathway taken.
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Concluding remarks
Herpesviruses are a paradigm for viral fusion that requires multiple glycoprotein
components. Herpesvirus fusion mechanisms have been refractory to study due to their
complexity. This dissertation addresses a question of fundamental importance; why do
herpesviruses require acidic pH for the initiation of infection? This work provides
evidence that the core fusogenic protein, gB is triggered by the cellular cue, endosomal
pH. Drugs that inhibit the identified conformational changes in gB, are of potential
therapeutic benefit. Studying HSV glycoproteins is of paramount importance to vaccine
development as the most successful vaccines to date have been glycoprotein subunit
vaccines. The findings presented here have shaped our current understanding of
herpesviral fusion in entry.
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